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Abstract 
English Version:  
Context: Prior research widely reaches the consensus that Palliative Care (PC) has proven 
clinical benefits. However, far less is known about the economic impact of PC. This thesis 
contributes to the existing literature by providing a comprehensive overview of PC costs oc-
curring in individual organizational units and cost types from the perspective of a European 
mixed funded health care system. The objective of this thesis is to identify cost drivers of PC 
and to quantify their effects on hospital costs. 
Research Question: Does PC reduce hospital costs for adult patients with a non-accidental 
death? 
Methodology: The research design of the retrospective, observational cost analysis is based 
on administrative and medical patient data for all inhospitalised deaths in 2015 in a large aca-
demic University hospital in Switzerland. The thesis consists of three separate cost analyses, 
of which the first compares hospital costs for patients receiving PC to costs for usual care (UC) 
patients using the propensity score, i.e. inverse probability weighting. The second and third 
analyses focus on PC patients only. These sub-studies compare the costs of a patient’s pre- 
and post-intervention hospital stay as well as investigate the role of the timing of PC interven-
tions. Hereby, the costs for patients who receive a PC intervention during the first three days 
of their hospital stay (early PC patients) and patients who receive a PC intervention after three 
days of their hospital stay (late PC patients) are compared using the bootstrap method. 
Results: The first cost analysis provides heterogeneous results regarding the hospital costs 
for PC and UC patients. Average daily costs are lower for PC patients compared to UC pa-
tients. However, due to the on average significantly longer hospital stays of PC patients, total 
costs are on a similar level for the two groups. Considering total ward costs only, costs are 
significantly higher for PC than for UC patients. Therefore, no unambiguous statement can be 
made, whether PC patients indeed have lower hospital costs as compared to UC patients. The 
second analysis reveals that hospital costs increase after a patient receives a PC intervention. 
The results of the third analysis show that late PC patients have higher hospital costs than 
early PC patients. Therefore, the timing of a PC intervention is of major importance pursuing 
a cost avoidance strategy.  
Conclusion: The thesis provides empirical evidence supporting decision-makers and  
management accountants of the cost avoidance potential of PC interventions from different 
cost perspectives. The results contribute to the literature comprehensive information on hos-
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pital cost drivers by shedding light on costs from different organizational units as well as indi-
vidual cost types of a hospital. This enhances transparency for internal and external stakehold-
ers and can serve as a potential controlling instrument. 
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German Version:  
Kontext: Bisherige Forschungsergebnisse stimmen weitgehend überein, dass «Palliative 
Care» (PC) einen erheblichen klinischen Nutzen bieten kann. Über die wirtschaftlichen Aus-
wirkungen von PC ist indes wenig bekannt. Diese Dissertation trägt zur bestehenden Literatur 
bei, indem sie eine umfassende Analyse der Kosten von PC unter den Rahmenbedingungen 
eines europäischen gemischt finanzierten Gesundheitssystems liefert. Dabei werden die Kos-
ten einzelner Organisationseinheiten sowie die Kostenarten eines Spitals untersucht. Die Ar-
beit zielt darauf ab, Kostentreiber von PC zu identifizieren und deren Auswirkungen auf die 
Spitalkosten zu quantifizieren. 
Forschungsfrage: Senkt PC die Spitalkosten für erwachsene Patienten, welche an einem 
nicht-unfallbedingten Tod verstorben sind?  
Methodik: Das Forschungsdesign der retrospektiven Kostenanalyse basiert auf administrati-
ven und medizinischen Patientendaten für das Jahr 2015 bezüglich inhospitalisierter Todes-
fälle eines grossen akademischen Universitätsspitals in der Schweiz. Die Dissertation besteht 
aus drei separaten Kostenanalysen. Mithilfe der Propensity Score-Methode (inverse probabi-
lity weighting) vergleicht die erste Analyse die Spitalkosten von PC Patienten mit den Kosten 
von «usual care» (UC) Patienten. In der zweiten und dritten Analyse werden ausschliesslich 
PC Patienten unter Anwendung der Bootstrap-Methode untersucht. Dabei werden einerseits 
die Kosten eines Spitalaufenthalts vor und nach einer PC Intervention verglichen. Zum ande-
ren wird die Bedeutung des Zeitpunkts einer PC Intervention untersucht, indem die Spitalkos-
ten von Patienten mit einer frühen PC Intervention den Kosten von Patienten mit einer späten 
PC Intervention gegenübergestellt werden.  
Ergebnisse: Die erste Kostenanalyse liefert heterogene Ergebnisse bezüglich der Spitalkos-
ten für PC und UC Patienten. Die durchschnittlichen Kosten pro Tag sind geringer für PC Pa-
tienten als für UC Patienten. Aufgrund des im Durchschnitt deutlich längeren Spitalaufenthal-
tes von PC Patienten sind die Gesamtkosten beider Gruppen jedoch auf ähnlichem Niveau. 
Der Teil der Gesamtkosten, welcher auf der Normalstation entsteht, ist für PC Patienten signi-
fikant höher als für UC Patienten. Daher kann keine allgemeingültige Aussage getroffen wer-
den, ob PC Patienten im Vergleich zu UC Patienten tatsächlich geringere Spitalkosten verur-
sachen. Die zweite Analyse zeigt, dass die Spitalkosten steigen, nachdem ein Patient eine PC 
Intervention erhalten hat. Die Ergebnisse der dritten Analyse verdeutlichen, dass Patienten, 
welche nach drei Tagen Spitalaufenthalt eine PC Intervention empfangen («late PC-Patien-
ten») höhere Kosten verursachen als «early PC-Patienten», die während der ersten drei Tage 
ihres Spitalaufenthalts eine PC Intervention erhalten. Demzufolge ist der Zeitpunkt einer PC 
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Intervention von grosser Bedeutung für die Implementierung einer Kostenvermeidungsstrate-
gie. 
Schlussfolgerung: Die empirischen Ergebnisse der Arbeit sind bedeutsam für Entschei-
dungsträger und Controller im Spital, da das Kostenvermeidungspotenzial von PC Interventio-
nen aus verschiedenen Kostenperspektiven diskutiert wird. Der Beitrag der Dissertation zur 
bestehenden Literatur besteht darin, dass die Studie auf Basis detaillierter Kostendaten um-
fassende Erkenntnisse über die Kostentreiber eines Spitals liefert, indem sie verschiedene 
Organisationseinheiten sowie einzelne Spitalkostenarten berücksichtigt. Die Arbeit erhöht die 
Transparenz für interne und externe Stakeholder und kann als potenzielles Steuerungsinstru-
ment dienen.
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1 Introduction 
1.1 Motivation 
While people spend an enormous amount of time preparing for birth by gathering information 
from pregnancy books and websites, discussions with parents as well as attending compre-
hensive prenatal classes, hardly anyone likes to talk about death. Preparing for one’s own 
death by deciding how and where to die makes, most people feel very uncomfortable, mostly 
they are afraid of death. However, just like birth, death is an inevitable part of every life and, 
therefore, concerns all of us. A multidisciplinary approach trying to reduce this fear in our so-
ciety is PC, whose goal is to improve the quality of life for both the person with a life-limiting 
illnesses and its family (World Health Organization - WHO, 2018). 
In almost all countries worldwide, chronic diseases including inter alia heart disease, stroke, 
cancer, chronic respiratory diseases and diabetes are the major cause of death (Statistisches 
Bundesamt, 2018b). More than six out of ten people die because of a chronic illness (WHO, 
2005). Moreover, people increasingly decease in health institutions. In Germany, for example, 
more than 50 % of the population die in hospitals (Dasch et al., 2015). A development towards 
an institutional death became apparent in Switzerland from the 60s onwards. Nowadays, more 
than two thirds of the Swiss population (70.7 %) die in an institute (37.2 % die in hospitals). 
Technological improvement as well as societal expectations are largely responsible for the 
considerable amount of people who have an institutionalized death (Fischer et al., 2004). The 
demographic development towards an older population will accelerate this trend.  
In this process of change, the population’s awareness level concerning PC has increased. A 
considerable number of studies demonstrate that PC programs improve the quality of care at 
the end of life, reduce symptoms and lead to a higher patient, family, and physician satisfaction 
as compared to curative treatments on regular wards. However, there is a lack of European 
research with respect to the economic side of PC (Higginson et al., 2002; Teno et al., 2004; 
Morrison, 2008).  
There are several reasons why the examination of PC from an economic perspective is crucial: 
One of the main global challenges in the next years in developed countries with a high standard 
of care is to keep a fundable health care system. For the first time in history, health care ex-
penditures in Germany exceeded the one billion Euro per day mark with an increasing ten-
dency in 2017. This results in a relative share of German health care expenditures on the 
Gross Domestic Product of 11.3 % (Statistisches Bundesamt, 2018a). In Switzerland, a similar 
trend is apparent. Health care expenditures have been rising every year since 1990 by about 
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2 %. The relative share of health care expenditures on the Gross Domestic Product was 8 % 
in 2010, whereas it grew to 12.1 % in 2015 (Bundesamt für Statistik, 2017). 
Lynn and Adamson show that major health care costs incur in particular in the last months of 
a patient’s life (Lynn and Adamson, 2003). Figure 1 illustrates this observation. The grey area 
under the curve equals 100 % of all health care expenditures of a human life span.  
 
Figure 1: Expenditures over a life span (Lynn and Adamson, 2003) 
In Switzerland, end of life options with PC programs are relatively rare compared to other 
countries, such as the United Kingdom, Belgium or the Netherlands (Leybold-Johnson, 2016; 
Woitha et al., 2016). The focus still lies on acute and curative treatment. Even though hospitals 
have only few possibilities to balance quality and costs, one controlling instrument for Swiss 
hospitals might be an increasing implementation and promotion of PC not only for quality rea-
sons, but also to save costs at the end of life (Simoens et al., 2010). 
1.2 Research Objective  
In spite of the fact that the social benefit of PC programs is scientifically confirmed, hospitals 
increasingly have to prove financial justification for their health offers, as economic pressure 
also weighs on the Swiss healthcare sector (Bendaly et al., 2008). Thus, evidence from eco-
nomic evaluations by demonstrating the financial impact supports the owners of hospitals as 
well as other hospital stakeholders to allocate resources for health care services in the best 
possible way (Bendaly et al., 2008; May et al., 2014; Khandelwal et al., 2016). Consequently, 
also PC costs need to be justified. Hence, a crucial aspect for PC decision-making processes 
in hospitals is to understand, whether PC contributes to lowering hospital costs (Smith et al., 
2009; Khandelwal et al., 2016). This thesis analyses the end of life care. Its focus is exclusively 
drawn on death discharges and excludes all patients that died because of an accident for 
reasons of comparability. The thesis examines the following research question: 
 
 
 
Does Palliative Care reduce hospital costs for adult patients with a non-accidental 
death? 
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Shedding light on this research question, the research objective of this thesis is twofold: (1) 
First, the thesis aims at giving a proper systematic literature review on the cost comparison 
between PC and UC in hospitals. The aim is to find out which financial components are subja-
cent. (2) Second, the thesis conducts a retrospective observational analysis that compares the 
costs of usual treatment to PC intervention taking the disaggregated financial cost components 
of PC into account. Hereby, the study provides a consecutive medical record review of both 
health and financial data of all patients who died in 2015 while being inhospitalised at the 
Inselspital (University hospital Berne in Switzerland).  
1.3 Outline of the Study  
The thesis comprises seven chapters: 
The first chapter outlines the relevance of the research project, explains the motivation behind 
it and develops the study’s research question.  
The second chapter provides the conceptual foundation of the study including the definition 
of PC and describes different types of economic evaluations. It also gives an overview of sta-
tionary and ambulatory accounting practices in Swiss hospitals.  
Based on this study’s research objective, the third chapter provides a review of existing stud-
ies that compare the cost of PC to those of UC in hospitals. Implications for this study are 
derived from the discussion of the prior studies’ results.  
On the basis of these theoretical implications and the literature review, the fourth chapter 
develops and formulates three main research hypotheses to be tested.  
The fifth chapter outlines the research design. First, the sample selection as well as the clin-
ical and financial data are shown. Afterwards, the chapter describes the methodology of the 
studies. 
The empirical results of this thesis are presented in the sixth chapter. This includes the sam-
ple description as well as the financial results. It further discusses the findings and provides 
answers to the tested hypotheses from chapter four. 
The conclusion in the seventh chapter summarizes and discusses the main results of the 
studies and provides implications for multiple stakeholders in the healthcare sector. Further-
more, it discusses limitations of this thesis and provides an outlook with respect to further 
research.  
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2 Conceptual Foundation 
2.1 Palliative Care 
Being a relatively new and rapidly growing health care field, PC has recently engendered a 
great deal of interest (Fitzpatrick et al., 2018; McCarthy et al., 2015; Cowan et al., 2004). The 
concept of PC emerged in the late 1950s by Dr. Cicely Saunders who focused on the care of 
the dying (Loscalzo, 2008). The WHO defined PC as “[…] an approach that improves the qual-
ity of life of patients and their families facing the problem associated with life-threatening ill-
ness, through the prevention and relief of suffering by means of early identification and impec-
cable assessment and treatment of pain and other problems, physical, psychosocial and spir-
itual.” (WHO, 2018). Therefore, a typical PC delivery model consists of an interdisciplinary 
inpatient PC consultation team covering the disciplines of medicine, nursing, social work, chap-
laincy, pharmacy, physical and occupational therapy, psychology counseling; in addition vol-
unteers and other health care professions can be part of this team (von Gunten et al., 2002).  
In particular, the following four institutions use PC: hospitals, home-based care, hospices and 
nursing homes (McCarthy et al., 2015). In this study, the focus lies on the hospital-based PC 
program that focuses on pain and symptom management, communication and objectives of 
care, support for complex medical decision making and assistance with transitions among sites 
of care for patients with advanced illness and their families (Morrison et al., 2011; Penrod et 
al., 2010). Accordingly, an inpatient PC intervention can be both: a treatment on the PC ward 
as well as a consultation by the PC team on all other wards within the hospital. 
With respect to the benefits of inpatient PC, the existing international literature agrees that 
there is an improved quality of care and satisfaction not only to the patient and families, but 
also to the caregivers and health care professionals (Chand et al., 2013; Wentlandt et al., 
2016). For instance, Wendtland et al. (2016) find that the key elements of quality care and 
patient satisfaction are, inter alia, an interprofessional team, communication, attentive, person-
alized and family centered care, appropriate resources and adequate staff as well as a sup-
porting setting. 
Nevertheless, Switzerland has a short history of encouraging PC with more awareness of cu-
rative treatment, acute care and assisted suicide as end of life options (Leybold-Johnson, 
2016). Table 1 gives an overview of the numbers of certified PC institutions in Switzerland as 
compared to the total number of Swiss institutions (qualitépalliative, 2018). While in the USA 
60 % of the hospitals report the presence of a PC program, in Switzerland 7.8 % of stationary 
institutions run a PC program (Morrison et al., 2011). 
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Table 1: Palliative care institutions in Switzerland (qualitépalliative, 2018; Bundesamt für Statistik, 2017b; 
Bundesamt für Statistik 2017c) 
According to the “Federal Statistical Office in Switzerland” (Bundesamt für Statistik), in 2015 
the proportion of the population aged 65 years and older was 18 %. The Bundesamt für Statis-
tik estimates that in the year 2045 this share will increase to 26.4 % (Bundesamt für Statistik, 
2015). These numbers imply in the long run an ageing population and, as consequence, a 
growing number of people in the need of care.  
The demographic development further implies a change in the number of yearly deaths. While 
in 2015 about 68’000 Swiss people died, it is estimated that until 2060 the number of deaths 
will increase by 33 % up to 102’000 per year (Bundesamt für Statistik, 2010). The health care 
system must be prepared that the care for people in the last phase of life is becoming more 
complex and, therefore, the increasing use of PC will be inevitable (Bundesamt für Gesundheit 
und Schweizerische Konferenz der kantonalen Gesundheitsdirektorinnen und -direktoren, 
2012). Thus, keeping a balance between the quality of care at the end of life and its incurred 
costs will be a challenging task for health care systems in the near future (Simoens et al., 
2010). 
2.2 Economic Evaluation Approach 
From an economic perspective, the rising demand for PC results in the need for more re-
sources, such as staff, infrastructure and medication. Nevertheless, medical systems do not 
possess unlimited funds for the prevention, cure or palliation of certain diseases. Hence, sys-
tematic, objective and quantifiable methods are necessary to evaluate health care programs 
and therapies. Based on this examination, the available resources should be allocated reason-
ably (Bruner, 1998). 
Rudmik and Drummond describe this so-called economic evaluation “as comparative analysis 
of alternative courses of action in terms of both their costs and consequences.” (Rudmik and 
Drummond, 2013). The purpose of the economic evaluation is “[…] to analyze the benefits and 
costs of health care interventions with the intention of prioritizing the use of scarce resources 
to achieve a maximum social good.” (Bruner, 1998). Table 2 summarizes four combinations of 
the main approaches that are currently in use throughout the literature: 
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Table 2: Methods of economic evaluation (following Robinson, 1993; WHO, 2003) 
The cost-minimization analysis is a method of calculating costs to project the least costly mo-
dality (e.g. for specific medications). It can only be used to compare two products that have 
been shown to be equivalent in outcomes (e.g. dose and therapeutic effect). A more compre-
hensive look has the cost-effectiveness approach. It measures the incremental cost of achiev-
ing an incremental health benefit expressed as a particular health outcome (e.g. life years 
gained). Cost utility analyses determine costs in terms of utilities, thus, expressing the value 
for money by estimating the effectiveness using measures that reflect individual or societal 
preferences for differing health states (e.g. quality-adjusted life years - QALY1). This thesis 
applies the cost-benefit approach. In this method of economic evaluation, cost of the interven-
tion is compared with the benefit incurred from the intervention. Therefore, direct calculation 
of the net monetary cost of achieving a health outcome is possible. It allows determining, firstly, 
whether an individual intervention offers an overall net welfare gain and, secondly, whether the 
welfare gain from that intervention, if it exists, is higher or lower than alternative interventions 
(Robinson, 1993; Palmer et al., 1999; WHO, 2003; Cohen and Reynolds, 2008; Adkhiaki, 
2017). 
The costing framework of PC consists of direct and indirect costs (overhead costs). While di-
rect costs can be completely attributed to medications, procedures, or services, indirect cost 
are not directly related to any service and oblige many different departments. In terms of hos-
pital care, direct costs include, inter alia, patient care supplies, medication, imaging, pharmacy, 
room and board as well as depreciation costs. Hospital overhead costs, such as general hos-
pital administration, cleaning or facility services as well as information technology, are more 
difficult to assign to a patient and, therefore, are considered to be indirect or shared costs 
(Albanese et al., 2013; Rudmik and Drummond, 2013; Morrison et al., 2008). 
                                              
1 A QALY reflects a "measure of the state of health of a person or group in which the benefits, in terms of length of 
life, are adjusted to reflect the quality of life. One QALY is equal to 1 year of life in perfect health." (National 
Institute for Healthcare and Care Excellence, 2018) 
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2.3 Stationary Accounting 
Direct as well as indirect stationary costs are both represented in different types of reimburse-
ment schemes. Table 3 gives an overview of the main hospital payment models. 
 
Table 3: Major hospital payment models (WHO, 2007; Lindenauer et al., 2007; WHO, 2013, Mathes et al., 
2014) 
The reimbursement model “fee-for-service” has the the advantage of high quality as well as 
high accessibility for patients. On the other side, however, it might be prone to delivering more 
services than actually needed. There is further the risk of physician-induced demand due to 
information asymmetries between patients and providers. Similar to the model “fee-for-ser-
vice”, the payment model “pay-per-diem” also encourages providers to deliver more and better 
services, but includes no incentives to consider costs in the decision-making process. This 
payment model might lead to longer hospital stays than actually needed. The reimbursement 
schemes “capitation” and “budget” have no financial incentive to increase quality, but have a 
strong effect on cost containment. This potential advantage is also associated with the “case-
base reimbursement” which is expected to reduce unnecessary care measures. On the other 
hand, the latter approach the “case-based reimbursement” approach encourages both to in-
crease the number of admissions as well as to offer fewer services per case and, thus, carries 
the risk of decrease the quality of services (Lindenauer et al., 2007; WHO, 2007; WHO, 2013; 
Mathes et al., 2014) 
To minimize risks and compensate for the weaknesses of individual reimbursement models, 
there is a tendency to use different provider payment methods simultaneously. Countries such 
as the Czech Republic, Denmark, Finland, Italy and New Zealand combine capitation and fee-
for-service payment models. Australia, Germany, Hungary and Norway, for instance, use a 
combination of case-based reimbursement and budget (WHO, 2007). 
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In Switzerland, the payment model “case-based reimbursement” is predominant. One form of 
this reimbursement scheme is the diagnosis related group (DRG) system that is a payment 
structure in which a provider receives a lump sum payment to cover an episode of care pro-
vided during a specific period of time (Radu et al., 2010; Smith and Cassel, 2009).  
Like a considerable number of countries before, Switzerland has implemented the SwissDRGs 
for hospitals in the year 2012 (Padiyath, 2013). The main objective is that efficient hospitals 
are able to be profitable through increased activity and shorter lengths of stays (LOS), whereas 
inefficient ones are incentivized to optimize processes (Maynard, 2008; Mateus, 2011). 
There are about 1’000 different SwissDRGs. They are all represented in the SwissDRG cata-
log, which is updated by the institution “SwissDRG AG”2 every year. Each SwissDRG is derived 
from the patient medical record for the specific treatment case. The most important criterion is 
the principal diagnosis. Moreover, inter alia secondary diagnoses, procedures, age, gender, 
the medical case including all provided services are considered when determining a Swiss-
DRG (SwissDRG AG, 2018a; Holzer, 2012; Fischer, 2015). 
In addition to a specific alphanumerical four-digit code3 calculated through an algorithm cre-
ated by a grouper software4, each SwissDRG is defined by an individual cost weight (CW). 
This is an empirically determined relative weight describing the average treatment effort of a 
given group of patients (SwissDRG AG, 2018a). A CW of 1.000, for instance, describes an 
average severity level or treatment effort, respectively, whereas the CW of 2.435 describes for 
example the rejection of an organ transplantation with an above average severity level. The 
sum of all CW in a hospital divided by the number of cases represents the Case Mix Index 
(CMI), i.e. the average severity level of a hospital (SwissDRG AG, 2018a). Typically, a Univer-
sity hospital has a higher CMI than a regional hospital.5 Within a hospital, a PC department 
usually has a relatively high CMI due to its complex patient cases, for example, higher than 
the ophthalmology department.  
 
                                              
2 SwissDRG AG is a joint institution of service providers, insurers and Cantons in the Swiss health care system. It 
is responsible for the introduction, further development and maintenance of the stationary tariff structures 
(SwissDRG AG, 2018a). 
3 For instance, SwissDRG B70C: Apoplexy with neurological complex treatment of an acute stroke: The first letter 
describes the cause of the illness (e.g. B = disorders of the nervous system). The two-digit number explains the 
treatment process, where the numbers 01-39 stand for operative or chirurgical treatments, 40-59 for invasive 
procedures and 60-99 for conservative treatments). The last letter describes the severity level of the illness 
which consists of four levels (A = highest severity level to D = lowest severity level). 
4 A grouper software is an economic-medical electronic data processing-system (SwissDR AG, 2018b). 
5 The CMI of the Inselspital in the year 2015 was 1.488. 
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LOS limitations are another essentially key figure for SwissDRGs. These limitations include 
surcharges or reductions depending on exceeding or underrunning the given time of stay. Ad-
hering to the individually pre-defined average length of stay (ALOS) suggests that the case 
was economical. Exceeding the ALOS, e.g. due to complications, is considered to be uneco-
nomical in most cases. 
The reimbursement for every SwissDRG is based on the current Cantonale base rate6 by mul-
tiplicating the base-rate with the applicable SwissDRG CW. Insurers and service providers 
determine the price of the base rate each year (Maynard, 2008; Mateus, 2011). 
2.4 Ambulatory Accounting 
For ambulatory medical services, a fee schedule, called “Tarmed”, was established in Switzer-
land in the year 2000 (Zweifel and Tai-Seale, 2009). Tarmed is an individual-service remuner-
ation system with more than 4’600 items, which cover most of the medical treatments in a 
medical practice and in the ambulatory hospital sector (Halter, 2013; FMH, 2018). The Tarmed 
system allocates a certain amount of points called “Tarmed-Taxpoints“ depending on the time, 
complexity and necessary infrastructure to each treatment. The amount of Tarmed-Taxpoints 
for each medical service is listed in the Tarmed-database (Schindowski, 2016). 
Each Tarmed-Taxpoint has a certain monetary value between CHF 0.82 and CHF 1.00 de-
pending on the Canton, the insurance (e.g. accident insurance, health insurance) and the in-
stitution (e.g. private practice, hospital) (Zentralstelle für Medizinaltarife, 2018). A certain qual-
itative doctor's dignity (e.g. certificate of competence) is required to account for a certain ben-
efit at the expense of the social insurers (Halter, 2013; FMH, 2018).  
As an example, the most frequently used position in the Tarmed-database is “00.0010: First 5 
minutes of a consultation” associated with 17.76 Tarmed-Taxpoints. The Tarmed-Taxpoint 
value in the Canton Bern for a health insurance case in a hospital is CHF 0.86 which means 
that a physician can charge CHF 16.61 (= 17.76 Tarmed-Taxpoints x CHF 0.86) for the above 
service (Schindowski, 2016). 
For internal accounting purposes, hospitals often use the Tarmed-Taxpoints as a key variable 
to assess the characteristics and success of a hospital. The indicator does not allow to record 
all activities of the medical service providers with the same key variable, but to put appropriate 
weights on these activities (Klockhaus, 1997). Even though this analysis causes considerable 
                                              
6 E.g. the base rate in the Canton Bern in the year 2015 was CHF 11’000 for the Inselspital and CHF 9’590 for other 
hospitals (Gesundheits- und Fürsorgedirektion des Kantons Bern, 2015). Of these amounts, the Cantons pay 
55 %, whereas the share of the health insurance companies is 45 %. 
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effort, analysists are thereby able to prepare a realistic activity evaluation on the basis of reli-
able and comparable results of cost center accounting data (Hesse et al., 2013). 
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3 Literature Review 
3.1 Review Method  
The objective of this systematic literature review is to give an overview of the existing literature 
concerned with the cost of PC by contrast to usual care (UC) costs in hospitals. In this thesis, 
PC comprises all PC activities such as both treatments on PC wards and PC consultations. 
UC, on the contrary, covers all other acute and curative hospital treatment. The literature re-
view was conducted in July 2018. Additional references of relevant articles are identified 
through grey literature searches. The search strategy employs a list of terms grouped under 
two main terms to identify all relevant publications (the search strings can be found in Appendix 
I): life stage (e.g. palliative care, end of life, last year of life) AND costs (e.g. cost-effectiveness, 
economics, finance). All of these studies found, based on this search methodology, were gen-
erally considered for inclusion in the literature review.  
Studies are excluded if they do not contain an economic evaluation of a specialist-led multidis-
ciplinary PC consultation team to adult patients (age > 18 years) in the hospital inpatient setting 
(e.g. exclusion of ambulatory care, hospice, elderly homes) as well as not measure and com-
pare the costs and/or cost effectiveness of the intervention of PC against a UC comparator. 
Lastly, the search strategy is limited to articles written in the English and German language. A 
particular publication period is not selected.  
The electronic database search provides 9’502 potentially relevant records to be screened. 
Title review leads to the manual exclusion of 8’149 articles, leaving 44 titles to be fully exam-
ined. Based on the inclusion criteria, 28 articles are excluded due to the observation of, for 
instance, two setting like elderly homes and hospitals. Finally, 16 empirical studies are identi-
fied assessing and comparing the costs of PC to UC in hospitals (see Figure 2). 
 
Figure 2: Flow diagram "PRISMA 2009" following Moher et al., 2009 
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3.2 Results 
Table 4 summarizes the key characteristics of the 16 studies selected for the literature review. 
Six of these 16 studies distinguish between life and death discharges which leads to 22 anal-
yses. Besides the year of the publication, the name of the author(s), the country of origin, the 
table also lists the study period and design. The sample size is divided into discharges of the 
intervention group, which includes the PC patients and into discharges of the control group 
consisting of UC patients.  
The 22 analyses observe in total 25 different PC research objectives, for example “total costs”, 
“Intermediate care unit (ICU) days” and “nursing costs”, sort by frequency. The grey shaded 
fields in the table show which objective is examined in each study. The fields with black mark-
ing indicate that the costs or number of days are higher for PC patients than for UC patients. 
In contrast, the studies with light grey shading observe the opposite. For the one result with 
grey striped color, the LOS was exactly the same for UC and PC patients. While the asterisks 
as well as “sig.” in the marked fields show the significance of the results7, the empty fields 
indicate that there is no significant result. 
The earliest study found was published in 2003, the latest in 2018 with most studies published 
in 2008. All studies except for one study from Belgium are from the United States (US). The 
number of people within the intervention groups varies from 38 to 4’908 patients, the study 
periods range from eight months to six years. 13 studies use retrospective research designs, 
whereas three are prospective studies. The top three principal diagnoses from the observed 
patients are cancer, pulmonary and cardiovascular diseases.  
In total, the 25 different PC research objectives are tested 124 times. However, none of the 
studies tests the exact same research objectives as another one. 80.6 % (100 objectives) of 
the objectives result in lower costs or days for PC patients compared to UC patients, whereof 
for 55.0 % (55 objectives) the studies find a significant difference between UC and PC patients.  
In 2010, for the first time, a published investigation provided evidence that PC would be more 
expensive or require more days than UC. Penrod et al. (2010), in contrast, find that even 
though the LOS was significantly longer for PC patients as compared to UC patients, a signif-
icantly smaller proportion of PC hospitalizations included an ICU stay. In total, 18.5 % (23 
objectives) of all tested research objectives suggest that PC is more expensive or lasts more 
days than UC. Thereof, for 34.8 % (8 objectives) of those research objectives a significant 
result is found.  
                                              
7 *p<0.1; **p<0.05 and ***p<0.01; for all "sig.", no detailed numbers on significance level is given. 
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Table 4: Summary of the literature review 
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The most investigated research objective is “LOS” (18 analyses / 13 studies). While nine anal-
yses show that PC patients are longer inhospitalised than UC patients, eight analyses find the 
opposite. The results of the investigations suggest the same LOS for PC and UC patients. 
Solely, Penrod et al. (2010) and May et al. (2018) provide a significant result for the item LOS. 
The results for the item “ICU days” show a similar heterogeneity: four analyses demonstrate a 
longer stay in the ICU for PC patients compared to UC patients, another four analyses show 
the opposite. Each direction of results is supported by two analyses with significant results. 
The item “ICU admission” measures the number of patients that have been on the ICU for a 
period of time. Here again, contradictory results can be identified: three analyses show that 
the ICU admission is higher for PC patients compared to UC patients, another three analyses 
show opposite results. Two analyses in each direction have a significant result.  
The item “total costs per day” was measured in eleven analyses (7 studies). Ten analyses 
show that the average daily charges are less for PC than for UC patients. Eight of these anal-
yses (80 %) prove significant results. The greatest difference between PC and UC show Smith 
et al. (2003) where charges per day were 59 % lower for PC than for UC patients. The only 
European study examining Belgian hospitals shows significantly higher average daily charges 
for PC patients than for UC patients. The average costs per patient per day of 423 EUR for 
patients receiving PC were higher than the costs of 340 EUR for patients receiving UC 
(p=0.002). 
Most of the studies that investigate the research objective “total costs per day” also observed 
the objective “total costs” (11 analyses / 7 studies). Of these, eight analyses show a significant 
result where PC patients cause less total costs than UC patients. In the year 2003, Smith et 
al. show average total costs of USD 2’586 for UC patients and USD 1’095 for PC patients 
resulting in a cost difference of 59 %. Moreover, with respect to this item, only one analysis 
from Starks et al. (2013) finds the opposite cost direction. However, the result is not significant.  
Smith et al. (2003), Morrison et al. (2008), May et al. (2015) and May et al. (2018) examine the 
research objective “direct costs”. Hence, “direct costs” are subject to analysis in four studies 
and five analyses, respectively. Four of these analyses prove a significant difference suggest-
ing that PC patients have lower direct costs than UC patients. Solely, May et al. (2018) show 
the opposite result, which, however, is not significant. “Direct costs per day” were only ana-
lyzed by Morrison et al. (2008) proving that, for both live and death discharges, PC patients 
have on average significantly lower costs per day than UC patients.  
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In addition, the ancillary costs such as imaging, laboratory, pharmacy, ICU, management, pro-
cedures, tests as well as room and board costs were tested, however, using different ap-
proaches. All of the ten studies (47.6 %) examining ancillary costs include imaging, laboratory 
and pharmacy costs in the analyses. Charges were lower for PC patients than for UC patients 
in nine cases (90 %) for imaging and laboratory costs and in eight studies (80 %) for pharmacy 
costs. Of those ten analyses, Cowan et al. (2004) and Penrod et al. (2006) do not report any 
ICU costs. The research objective “ICU costs” was, therefore, tested in eight cases from 2008 
onwards and showed a 100 % consistent result representing that ICU costs are lower for PC 
than for UC patients. For another direct cost item “room and board” studies show mixed results. 
It was analyzed first in 2004 by Cowan et al., suggesting that charges are lower for PC than 
for UC patients (results not significant). In 2015, May et al. tested this item again and showed 
a significant result in the opposite direction.  
Withford et al. (2013) exclusively exam the items “procedure costs”, “test costs” and “manage-
ment costs” with no detailed description on what is meant by those research objectives. The 
first aforementioned items as well as “management costs” for all death discharges show higher 
expenses for UC than for PC patients. “Management costs” for the live discharges shows a 
significant result in the opposite direction. 
The research objectives “total variable costs”, “total variable costs per day”, “median charges”, 
“supplies and equipment”, “nursing costs”, “median DRG weight” as well as the specific medi-
cation “creatinine” and “albumin” are solely investigated once in different studies that have 
been published between 2004 to 2008. All of the results examine higher costs for PC than for 
UC patients. The research objectives “total variable costs per day”, “median charges”, “nursing 
costs” and “mean admission creatinine” show a significant result.  
3.3 Implications for this Study 
This section identifies implications of the literature review. Overall, most studies discussed in 
the literature review indicate that PC patients are less costly than its UC comparators. How-
ever, there is a trend that the more recent studies do not all show this direction for the tested 
research objectives. For instance, Withford et al. (2013) and May et al. (2015) are the only 
studies arguing that pharmacy costs are higher for PC than for UC patients. All studies before 
that time show a different result. Since almost all of the studies focus on the US with a private 
funded healthcare system, reasons for changing results might include the rising cost pressure 
in the American health care system and the demographic change towards an elderly society 
with more multimorbide illnesses. The results from the US cannot generally be transferred to 
a mixed private and social funded health care system, as it exists in Switzerland, for instance. 
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Therefore, a non-US setting allows to examine a different financing model in the health care 
sector.  
The findings of the literature review also reveal that there is a considerable variety of research 
objectives with some of them only being analyzed by one or two studies (e.g. supply and 
equipment costs, room and board costs). This leads to a limited comparability between the 
investigated research objectives. Less than half of the analyses show results concerning an-
cillary costs. Moreover, no study is separately analyzing staff costs, even though these account 
for most of the costs in a hospital. Being able to explain the benefits associated with all incurred 
costs in detail is an essential prerequisite to make use of political and managerial decisions 
under consideration of the interests of health insurances and tax payers. Therefore, a detailed 
analysis of those costs is vital. Such an analysis can be based on a validated cluster model 
that allocates all incurred costs to pre-defined and in understandable categories. 
The majority of the above studies solely give an overview of the patients’ major principal diag-
noses. Only the Belgium study by Simoens et al. (2010) compares the costs of PC and UC 
considering different types of hospital wards (cardiology, geriatrics, and oncology). Hereby, 
however, the study does not distinguish between different medical groups. Understanding the 
differences among the cost structures of PC patients between different medical diagnoses 
might be relevant not only for health care payers, but also for the involved hospital employees 
to allocate the limited resources adequately and efficiently. 
Finally, the literature review revealed a lack of research concerning the cost of specific medi-
cation in different illness groups given to patients on their last days of life. None of the afore-
mentioned studies provides a comprehensive investigation of this important aspect. 
Particularly the contradicting results in prior research as well as the concentration on private 
funded healthcare systems make additional examinations necessary, which can be compared 
comprehensively to prior findings.  
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4 Hypotheses Development 
The following section derives the research hypotheses of this thesis’ empirical investigation 
based on the conceptual foundation and the literature review. The research hypotheses are 
examined to generate evidence for answering the main research question whether PC can 
reduce hospital costs for adult patients with a non-accidental death (see section 1.2). Hospital 
costs in the following cover both perspectives: total costs per patient and costs per day per 
patient. 
There is evidence that the provision of PC for patients with chronic and serious illness in hos-
pitals can lead to fewer ICU admissions as well as lower ancillary costs such as ICU, phar-
macy, laboratory and imaging costs (inter alia Gade et al., 2008; Penrod et al., 2010; Meier 
and Beresford, 2009). Such a lower intensity of treatment can be an indicator that overall hos-
pital costs are reduced for PC patients. Even though cost estimates reported in the studies 
discussed in chapter 3 tend to be country specific (particularly US studies), and thus, are con-
centrating on a private funded healthcare system, also for a mixed private and social funded 
health care system as it exists in Switzerland the following hypothesis assumes (Simoens et 
al., 2010):  
Hypothesis 1 
Hospital costs are lower for PC patients compared to UC patients 
who died in the hospital. 
The second analysis focuses exclusively on those patients who have received a PC treatment 
either on a PC ward or in the form of a consultation by the PC team on another ward in the 
hospital. The objective is to evaluate the economic impact of the PC intervention overall by 
comparing PC patients’ pre- and post-intervention costs. Since staff costs tend to rise after a 
PC intervention due to a personnel-intense care effort, other charges like pharmacy, laboratory 
and imaging are reduced by the intervention according to the literature review (McCarthy et 
al., 2015). Although, the average staff costs of all Swiss hospitals account for 64.5 % of the 
revenue (PwC, 2018), it is assumed that the decrease of ancillary costs overweights the ex-
pected increase in staff costs. This leads to the following hypothesis: 
Hypothesis 2 
A PC intervention reduces hospital costs for patients who died in 
the hospital.  
The third analysis puts emphasis on the timing of a PC intervention. An early PC intervention 
is considered to be performed during the first three days of a patient’s hospital stay. A late PC 
intervention is any intervention later than three days after admission (Fitzpatrick et al., 2018). 
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There is little empirical evidence whether a late treatment has a negative economic impact. 
Prior studies demonstrate that an early PC intervention is associated with clinical benefits, 
which might imply a positive economic effect (May et al., 2015). In both of their studies from 
2015 and 2018, May et al. examine the treatment effect8 on direct hospital costs for different 
patient groups depending on the timing of their PC intervention after hospital admission in a 
US private funded health care setting. The results show that the earlier a PC intervention takes 
place after hospital admission, the smaller the estimated treatment effect on direct hospital 
costs gets. Based on these findings the following hypothesis shall be tested for the mixed 
private and social funded health care system in Switzerland: 
Hypothesis 3 
Patients with an early PC intervention have lower hospital costs 
compared to patients with a late PC intervention who died in the 
hospital.  
 
                                              
8 May et al. (2015) define the treatement effect as “the estimated mean effect on cost of moving a patient from 
comparison to treatment group, holding all other values constant”. 
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5 Research Design 
5.1 Sample Selection 
The sampling frame for this study is designed to capture all hospital admissions of patients 
who died between January 1 and December 31, 2015 in the Inselspital in Bern. A total of 976 
patients were identified from the hospital database. Each patient has its own patient identifica-
tion number (FID). Patients with dissent to further use of medical data (Human-
forschungsgesetz) were excluded from the initial sample. Along were children (patients 
younger than 18 years of age), perinatal deaths and patients who died due to an external cause 
such as an accident or an injury excluded from the study and thus, reduce the included number 
of deaths to 780. Furthermore, ambulatory patients and patients with missing cost data mini-
mize the number of patients included in the study to 746 (see Figure 3).  
The patients were classified as PC patients, if they were either treated as part of a stationary 
stay at the PC ward, a consultation was requested by the patient’s attending physician, the 
patient was seen and evaluated by the PC team for one or more visits, or at least one set of 
recommendations was made by the PC team for the primary team caring for the patient. Pa-
tients were classified as UC patients if their inhospitalised time after the PC intervention was 
less than 25 % of their total stay. In the end, 642 UC patients and 104 PC patients were in-
cluded in this study.  
 
Figure 3: Exclusion flowchart for initial sample list 
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The study was approved by the Cantonal Ethic Commission (Kantonale Ethikkommission 
Bern)9 as well as the the University’s Institutional Review Board from the department of re-
search and teaching10. 
5.2 Clinical and Financial Data 
In order to examine the earlier developed hypotheses, clinical and financial information data 
from several sources is required. Table 5 gives an overview of all hospital databases used for 
this thesis. 
 
Table 5: Applied hospital databases  
Clinical data for the analyzed deaths was derived from the patient characteristics database. 
On the one hand, this database provides administrative information about, age, sex, death 
date, residency and marital status. On the other hand, it stores medical data such as main 
diagnoses, main treatments, CMI and CW. The patient process database lists all inhouse 
movements of each patient, for instance, that a patient moves from emergency room to the 
gastroenterology department.  
From the hospital’s cost accounting system, the costs of each subject are retrieved for both 
each hospital day and the entire admission period. The activity records database gives infor-
mation about all services and items rendered (in the following called “activities”) including, inter 
alia, staff activities, materials, laboratory and catering. The latter also provides the exact date 
and time when the activity occurred. All services and items have a specific amount of Tarmed-
Taxpoints as weighting factor (see section 2.4). 
                                              
9 Reference number: KEK-BE 2017-00400 
10 Study Number: 3294 
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The sums of the costs for each FID are retrieved from the cost unit accounting database. It 
provides information about the costs per case and unit, however, does not have exact infor-
mation on the corresponding date nor differentiate between performances that are provided 
over a period of more than one day.  
As the activity records database does not include a detailed list of delivered medication, in 
addition, all inhouse medication databases need to be used in this study. This comprises the 
medication database of the regular ward (i-pdos), the medication database of the emergency 
room (e-care) as well as the medication database of the ICU (PDMS).  
5.3 Methods of Analysis 
5.3.1 Cluster Code 
Accessing and merging the seven different databases is necessary to obtain the required level 
of detail for this study. Therefore, a clearly labeled key code for each item in all of the data-
bases has to be developed to link the different data sources. Unlike most prior studies in the 
literature review, which examine individual PC research objectives (e.g. laboratory costs), this 
study captures all direct and indirect hospital costs. Consequently, the thesis develops a com-
prehensive cluster model allocating all costs to organizational units as well as to cost types 
and, in addition, to staff costs in detail (see Figure 4).  
 
Figure 4: Cluster model 
Cluster 1 groups 192 different organizational hospital units into six categories, representing 
the main locations of a patient process starting from the emergency room to the surgery room 
to the ICU, the radiology and, finally, the regular ward. Hotel costs comprise costs for hotellery 
services, such as room and catering services. As hotellery services are regarded as an addi-
tional organizational unit, this study analyses hotel costs separately and does not allocate hotel 
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costs to the five aforementioned organizational units. Figure 4, however, illustrates that ho-
tellery services can be related to the services of the other organizational units.  
Cluster 2 aggregates 23 different hospital cost types in eight major cost categories: catering, 
laboratory, material, patientmanagement, pharmacy, room, staff and other costs. 
Cluster 3 particularly analyses the staff costs in more detail by differentiating different types of 
staff costs. The thesis sorts all staff database items by nursing, physician, social counselling, 
and therapist costs. Other staff costs such as administration cannot separately be extracted 
from the system and are therefore part of individual cost types. A more detailed summary of 
both clusters 2 and 3 combined is shown in table 6. 
 
Table 6: Description of cost types 
The cluster model is the basis for the cluster code. As an exactly identifiable merging key, the 
cluster code is able to connect information from all seven databases. It consists of five com-
ponents. The first three are derived from the cluster model. In addition, the FID and the delivery 
date are added (see table 7).  
Components 
Component 1  Component 2 Component 3 Component 4 Component 5 
Cluster1= 
Cost unit 
Cluster2= 
Cost type 
Cluster3= 
Staff detail 
FID Delivery date 
Cluster code =  “Cluster1=Cost unit”_”Cluster2=Cost type”_”Cluster3=Staff detail”_”FID”_”Date” 
Table 7: Components of the cluster code 
For instance, an item with the cluster code “ICU costs_Staff costs_Nursing 
costs_123456_15.3.2015” gives details on the amount of activities (e.g. drug administration to 
a patient) a nurse for patient with the identification number 12345 has done on the exact date 
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of 15.03.2015. The cluster code “Surgery costs_Material costs_0_987654_29.8.15” explains 
how much material was used during surgery for the patient 987654 on the mentioned date. All 
recorded activities are represented and weighted in Tarmed-Taxpoints. Linking the perfor-
mance database with the cost accounting database allows us to distribute the costs for the 
specific cluster and FID.  
Table 8 illustrates an extract of the merged databases. The delivery date is on the top of the 
table. Each cluster code is represented by one row, which shows the Tarmed-Taxpoints from 
the performance database and the costs in CHF from the cost unit accounting database. For 
instance, the first cluster code “Ward costs_Staff costs_Nursing costs_4952902” in combina-
tion with the date “29.04.15” has a weighting Tarmed-Taxpoint value of 73 points (equivalent 
to CHF 106.67). On the next day, “30.04.15”, 592 Tarmed-Taxpoints are recorded suggesting 
that more nursing care was performed on that date. Therefore, a cost share of CHF 865.01 
falls on this day.  
 
 Table 8: Extract from merged database 
5.3.2 Statistical Analysis 
The analyses was done using Stata version 15 (StataCorp, 2017), SPSS version 25 (IBM 
Corp., 2017), Microsoft Excel version 25.11 (Microsoft Corp., 2015) and R version 3.5.1 (R 
Development Core Team, 2008).  
The sample characteristics describe the UC and PC patient groups. The baseline table in 
chapter 6.1.1 shows potential confounders including their mean. For continuous and categor-
ical variables, absolute and relative frequencies are presented. The thesis compares PC and 
UC patients using the Wilcoxon-Mann-Whitney and chi-squared test for continuous and cate-
gorical variables, respectively. An additional baseline table comparing early and late PC pa-
tients can be found in the Appendix II.  
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The results of the crude, unadjusted raw data are available in the Appendix III. It includes in 
the aforementioned all cost outcomes using two different methods. The first method calculates 
the mean and standard deviation for each group, comparison via linear regression with robust 
standard errors (Huber-White sandwich estimator) and estimates the mean difference with 
95 % confidence interval (CI) and a p-value based on the t-distribution. The second method is 
applied to show the median with lower and upper quartile, comparison using a Mann-Whitney-
Wilcoxon test and the Mann-Whitney statistic with 95 % CI. 
To provide meaningful comparisons between UC and PC patients (see chapter 6.2.2), the raw 
data analysis is adjusted using the inverse probability of treatment weighting with the propen-
sity score technique. Propensity scores present a method widely used in observational studies 
to adjust cofounding effects and to control for selection bias. The approach improves estimates 
of the effect of an intervention on costs (Starks et al., 2009; Austin, 2011; He et al., 2016). 
Propensity scores are derived by a logistic regression with “age”, “marital status” (as binary 
variable, married yes/no), “insurance class”, “primary diagnosis” and “location prior to entry” 
as covariates. A one-to-one matching with replacement and a caliper of 0.2 is used. For the 
inverse probability weighting, stabilized weights are used and potential outcome means are 
calculated based on weighted linear regression (Cole and Hernan, 2004). The mean differ-
ences are designed on 2’000 bootstrapped samples and reported as bias-corrected mean dif-
ferences with bias corrected 95 % CI. (Efron, 1987). P-values are derived using the bias-cor-
rected point estimate and the bootstrap standard errors with a normal approximation.  
Within the PC group, the unadjusted means for each group (pre- vs. post-intervention (see 
chapter 6.2.3)) and early vs. late PC intervention (see chapter 6.2.4)) are presented. Also, the 
mean difference is shown as bias-corrected mean difference (outcome mean difference) with 
bias-corrected 95 % CI calculated on 2’000 bootstrapped samples (Efron, 1987). For the anal-
ysis within the PC groups, p-values are calculated using the bias-corrected point estimate and 
the bootstrap standard errors with a normal approximation. 
Empirical Results  25 
6 Empirical Results  
6.1 Sample Characteristics 
6.1.1 Baseline Table 
After the description of the empirical field including the sample selection and the presentation 
of the research methodology of the different sub-studies in chapter five, this chapter presents 
the empirical results of the investigations. In particular, the research hypotheses, which have 
been developed in chapter four, are tested throughout this chapter.  
Table 9 presents the descriptive characteristics for both the UC and PC patient group and 
describes the following variables: age, gender, material status, citizenship, insurance class, 
primary diagnoses, location prior to entry, inhospital admission as well as ALOS and CMI.  
 
Table 9: Descriptive characteristics of the sample 
Empirical Results  26 
The average age for the unweighted sample shows a significant difference of 6.1 years 
(p=0.001) between UC and PC patients, whereas there is no significant difference in the pa-
tients’ gender (p=0.896) and citizenship (p=0.152). In both groups, more than 80 % of the 
patients are from Switzerland. Most of the UC and PC patients are married followed by the 
marital status “widowed” for UC patients (17 %) and “single” for PC patients (18 %), resulting 
in a significant difference between the two sub-samples (p=0.035). 
The majority (>77 %) of patients from both groups have a public insurance (p=0.291). The 
primary diagnoses differ between UC patients and PC patients significantly (p=0.000). More 
than half of the UC patients (59 %) die of a cardiovascular disease followed by malignant 
neoplasms (17 %) and infectious diseases (9 %). In the group of PC patients, most of the 
patients die of malignant neoplasms (74 %) followed by cardiovascular diseases (12 %).  
In the UC group, two thirds of the patients (66 %) are admitted to the University hospital from 
home and 30 % from other hospitals. On the other side, within the PC group, 84 % of the 
patients are admitted from home and only 10 % from another hospital. Further individual ad-
missions are from other institutions like elderly homes, psychiatric clinics and penal institutions, 
which only account for a minor percentage in both groups. Table 9 shows a significant differ-
ence (p=0.000) between both groups regarding “Location prior to entry”. 
While 65 % of all UC patients are admitted to the ICU, only 26 % of PC patients are admitted 
this way (p=0.000). Table 9 further reveals a similar treatment for patients from both groups 
regarding emergency room (p=0.003) and surgery room (p=0.000). Every patient from both 
groups also spent some time on the ward. A similar proportion of patients from both groups 
had a radiology treatment (p=0.210). 
Moreover, there is a significant difference in ALOS of 8.8 days (p=0.000). Whereas PC patients 
stay on average 16.0 days in the hospital, UC patients have an ALOS of 7.2 days. The CMI 
for PC patients is 0.8 points less (p=0.000) than for UC patients.  
6.1.2 Activity Records 
Figure 5 gives an overview of the number of activities recorded in different cost types (clus-
ter 2). For all 746 selected patients, 111’809 activities were extracted from the accounting sys-
tem. Most of the activities come from pharmacy (44.8 %) followed by staff (21.5 %) and labor-
atory (13.3 %). 
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Figure 5: Number of recorded activities (n = 746) 
Table 10 compares the total number of activities for UC and PC patients. On average, 128.1 
activities are recorded for a UC patient and 284.4 activities for a PC patient. Except for patient-
management, all cost types show a higher number of total activities for a PC patient than for a 
UC patient. The largest difference is found for pharmacy which has 93 % more recorded ac-
tivities for a PC patient than for a UC patient (p=0.000). Also, catering and staff costs show 
more than 50 % more activities recorded for a PC than for UC patient (p=0.000).  
 
Table 10: Descriptive statistics of total number of recorded activities (calculated for full length of stay)  
The ALOS is one factor contributing to this observation, since PC patients spend on average 
16.0 days in the hospital and UC patients 7.2 days. Therefore, the costs are additionally ana-
lyzed based on daily data in table 11. The average number of activities per day per patient still 
differs significantly between UC and PC patients, however, less than the total data in table 10. 
Based on a daily view, PC patients have on average 2.29 (16 %) more recorded activities per 
day than UC patients. Of these, catering and pharmacy show, on average, more recorded 
activities per day than UC patients. Since pharmacy accounts for almost half of all recorded 
activities (44.8 %), it is the main driver for the total number of recorded activities. Table 11 
reveals that all other cost types have less recorded activities for PC patients as compared to 
UC patients.  
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Table 11: Descriptive statistics of recorded number of activities per day  
6.2 Financial Analysis 
6.2.1 Cost Allocation 
The merging of the seven databases described in chapter 5.2 allows the allocation of the pa-
tients’ total costs by each category of the three clusters on the different days of stay. As an 
example, Figure 6 illustrates this allocation for one patient using all three clusters: organiza-
tional units (cluster 1), cost types (cluster 2) and staff detail (cluster 3). The numbers on the 
abscissas represent the days before and after the PC intervention with 0 being the day of the 
PC intervention. 
 
Figure 6: Example of a patient’s total cost allocation per day of stay 
The clusters “organizational units” and “cost types” demonstrate identical distributions, how-
ever, represent different categories. Cluster 3 splits the staff costs from cluster 2 into four staff 
groups: nursing, physician, therapist and social counselling. These distributions allow analyses 
from different hospital perspectives.  
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In the above patient example, the cluster 1 “organizational units” analysis reveals that the pa-
tient entered the hospital through the emergency room. The patient had surgery twice through-
out its stay and spent one day in the ICU (day 2). A radiological examination was carried out 
on six days immediately when entering the hospital (day -21) and on the days -17, -15, -9, -3 
and -2. While ward costs incurred on each day at different amounts, hotel costs are equally 
distributed amongst the LOS.  
The cluster 2 perspective “cost types” shows that a large share of the costs is associated with 
staff costs. On the days of the surgeries (day -9 and day -3) additional material was used. 
Laboratory costs mainly arose in the first days the patient’s stay. Pharmacy costs incurred on 
each day with the highest costs on the days of the surgeries. Patientmanagement costs, ca-
tering costs and room costs represent in this case the lowest costs in percentage terms. 
Cluster 3 “Staff detail” demonstrates that nursing costs occurred on every day. Physician costs 
are higher on the days of the surgeries and are not recorded on each inpatient’s stay. Therapist 
and social counselling treatments are performed irregularly.  
As illustrated by the dotted line on day 0 (“intervention day”), this patient’s LOS is in total 38 
days, of which 21 days were spent in the hospital before the PC intervention and 17 days 
(including day 0) after the PC intervention.  
In the following, the thesis’ hypotheses are tested from two cost perspectives, the average total 
costs per patient as well as the average costs per day per patient. The latter takes the different 
LOS into consideration, however, may be misleading since the cost-saving effect of an inter-
vention, which might reduce overall LOS, could be systematically underestimated (May, 2016). 
The hypotheses are tested from the two described cost perspectives. In addition, the two cost 
perspectives are observed from the scenarios “all organizational units” as well as “ward only”. 
The last mentioned scenario is important since UC patients admit an ICU and undergo surgery 
significantly more frequently than PC patients (see chapter 6.1.1). This focus reduces bias due 
to, for instance, pricey specialists or material in high-volume settings. 
For the above patient example (see Figure 6), table 12 provides the associated cost observa-
tions. The total costs for this patient example considering all organizational units are 
CHF 69’484, i.e. CHF 35’414 more expensive than the matched UC patient comparator. For 
ward only, the total cost difference is CHF 22’989. The LOS difference of 25 days between this 
PC and UC patient reverses direction of the results. The costs per day for the PC patient 
example is CHF 1’878, i.e. CHF 743 less per day than for the UC patient comparator. The 
difference between UC and PC patient increases (CHF 977) considering ward only costs. 
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In all four cost observations, a reduction can be noticed when comparing the cost of this PC 
patient example before and after the PC intervention. For instance, total costs for this patient 
example reduce on average by CHF 31’083 after this patient received a PC intervention. 
 
Table 12: Total costs and costs per day for patient example 
This cost distribution and cost allocation with its four cost measures is applied on the entire 
patient sample (n = 746) including all UC patients to examine this thesis’ hypotheses (see 
chapter 4). 
6.2.2 Palliative Care vs. Usual Care 
6.2.2.1 Total Costs 
This section presents the results of the UC vs. PC analysis from the perspective of total costs.  
 
Figure 7: Total costs comparing PC to UC patients 
Figure 7 illustrates that total costs per patient are 7 % (p=0.600) lower for PC patients than for 
UC patients. However, the large range of the confidence interval indicates that the difference 
between the two groups does not vary considerably. A clear result is displayed for total costs 
per patient considering ward only. Total ward costs are by 36 % (CHF 7’385) significantly 
higher for PC patients as compared to UC patients (p=0.038).  
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Figure 8: Total costs per organizational unit comparing PC to UC patients 
Focusing on the organizational units, figure 8 demonstrates that total costs per patient in emer-
gency room (p=0.730), hotel (p=0.000) and ward (p=0.038) are higher for PC patients com-
pared to UC patients. On the other side, total costs in radiology (p=0.000), ICU (p=0.000) and 
surgery room (p=0.150) are lower for PC patients than for UC patients.  
 
Figure 9: Total costs per cost type comparing PC to UC patients 
Examining the total costs for the different cost types comprising all organizational units (see 
figure 9), significant differences can be shown for laboratory (p=0.013), material (p=0.000), 
pharmacy (p=0.005), catering (p=0.000) and room costs (p=0.000). For the first three-men-
tioned cost types total costs are lower for PC patients than for UC patients. The latter two 
aforementioned cost types have higher costs for PC as compared to UC patients. Also for 
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patientmanagement (p=0.310) and staff costs (p=0.610), the analysis suggests that PC pa-
tients’ total costs exceed those of UC patients, however the results are not significant.  
 
Figure 10: Total costs per staff group comparing PC to UC patients 
The major factor boosting overall staff costs for PC patients is nursing (see figure 10) as total 
nursing costs are 112 % (CHF 9’625) higher (p=0.000) as compared to UC patients. In addition, 
social counselling costs for PC patients more than double the UC patients’ costs (p=0.000). 
Therapist costs also significantly increase by 85 % to CHF 757 per PC patient (p=0.005). The 
effect is compensated by lower physician costs (p=0.000), which on the contrary significantly 
decrease by 46 % (CHF 8’288).  
A separate analysis of the ward costs only is necessary to reduce the potential bias when using 
all organizational units due to the existence of treatment results of specialists in high-volume 
settings, such as ICU and surgery room, which UC patients visit more often than PC patients.  
 
Figure 11: Total ward costs per cost type comparing PC to UC patients 
For all cost types, the results presented in figure 11 are similar to the results considering all 
organizational units (see figure 9). In addition, this analysis shows that laboratory (p=0.070), 
material (p=0.000), other (p=0.620) and pharmacy costs (p=0.017) are less for PC patients 
Empirical Results  33 
than for UC patients. The greatest difference is found for staff costs which are significantly 94 
% (CHF 10’963) higher for PC patients than for UC patients (p=0.000). 
 
Figure 12: Total ward costs per staff group comparing PC to UC patients 
In particular, physician costs differ considerably as compared to the analysis, which captures 
all organizational units (see figure 12). For ward only, the difference between UC and PC pa-
tients decreases to CHF 323 per patient (p=0.690), however, physician costs are still lower for 
PC patients than for UC patients. The other staff costs are significantly higher for PC patients 
than for UC patients. Total nursing costs increase by 179 % to CHF 16’597 per PC patient 
(p=0.000). The results for total social counselling (p=0.000) and therapist costs (p=0.005) are 
widely unchanged as to the results of the analysis with all organizational units.  
6.2.2.2 Costs per Day 
In addition to the above total costs analyses, this section considers the significant longer LOS 
of 7.8 days for UC patients than for PC patients (see chapter 6.1.1). Hence, it analyses the 
average costs per day per patient. First, this analysis examines the costs per day for all organ-
izational units and, second, concentrates on the costs occurred on the ward only.  
 
Figure 13: Costs per day comparing PC to UC patients 
Considering all organizational units, figure 13 illustrates that costs per day are significantly 
58 % (CHF 3’224) lower for PC patients than for UC patients (p=0.000). For ward only, costs 
per day are 32 % (CHF 814) lower for PC patients than for UC patients (p=0.000). 
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Figure 14: Costs per day for UC and PC patients over the first 20 inhospitalised days 
Figure 14 presents an extract of the patients’ first 20 inhospital days showing the average cost 
distribution per day and patient considering all organizational units. The graphs illustrates that 
the average costs per day are lower for PC patients than for UC patients on each of these 20 
days.  
 
Figure 15: Costs per day per organizational unit comparing UC to PC patients 
Figure 15 illustrates that solely hotel costs per day (p=0.043) are higher for PC patients than 
for UC patients. The other organizational units show opposite results. In particular, radiology 
(p=0.000), ICU (p=0.000) and ward costs per day (p=0.000) are significantly below the corre-
sponding costs for UC patients.  
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Figure 16: Costs per day per cost type comparing UC to PC patients 
All findings from the cost type analysis comparing UC and PC patients show significant results 
(see figure 16). Out of the cost types, catering (p=0.000) and room costs per day (p=0.000) 
are higher for PC patients than for UC patients. The other cost types, such as laboratory 
(p=0.000), material (p=0.000), other (p=0.000), patientmanagement (p=0.000), pharmacy 
(p=0.000) and staff costs per day (p=0.000) show lower costs for PC than for UC patients. The 
largest difference is found for material costs per day, which are 89 % (CHF 1’105) lower for 
PC patients than for UC patients.  
 
Figure 17: Costs per day per staff group comparing UC to PC patients 
Nursing (p=0.280), social counselling (p=0.000) and therapist costs per day (p=0.000) are 
higher for PC patients as compared to UC patients (see figure 17). However, this effect is 
overcompensated by physician costs per day (p=0.000), which are significantly 33 % 
(CHF 1’644) lower for PC patients than for UC patients.  
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Figure 18: Ward costs per day per cost type comparing UC to PC patients 
Excluding personnel-intensive units by focusing on the costs per day for each patient that oc-
curred on the ward only, the results presented in figure 18 are similar to those found in the 
analysis including all organizational units (see figure 16). Laboratory (p=0.000), material 
(p=0.000), other (p=0.007) and pharmacy costs per day (p=0.000) are still significantly lower 
for PC patients as compared to UC patients. In contrast to the above “all organizational” anal-
ysis, an opposite observation can be shown for staff costs per day, which are 0.5 % (CHF 6) 
higher in the ward only analysis (p=0.970).  
 
Figure 19: Ward costs per day per staff group comparing UC to PC patients 
Daily costs of all individual staff groups for PC patients are above the corresponding costs of 
UC patients (see figure 19). Physician costs are 3 % (CHF 37) higher for PC patients as com-
pared to UC patients. All other staff groups, such as nursing (p=0.004), social counselling 
(p=0.000) and therapist costs (p=0.000) show costs difference between both patient groups 
on a significant level. 
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6.2.2.3 Interim Conclusion 
After presenting the separate studies in detail, this section provides an interim conclusion 
based on all of the above results. The analyses examine both total costs as well as average 
costs per day per patient for the three clusters developed in chapter 5.3.1. Table 13 summa-
rizes the cost differences observed between PC patients and UC patients. While a black 
shaded field with an upwards-facing arrow indicates that costs for PC patients are higher than 
for UC patients, a non-shaded (white) field with a downwards-facing arrow suggests the oppo-
site. The asterisk is added to an arrow if the results are significant on the 5 % level. Grey 
shaded fields are used for ambiguous results or costs that are not examined in any of the sub-
studies.  
 
Table 13: Cost difference comparing PC to UC patients 
With respect to all cost types aggregated (“Total costs”), costs per day per patient are lower 
for PC patients than for UC patients considering all organizational units as well as ward only. 
A different effect is found for total costs due to the significantly longer hospital stay of PC 
patients. Considering all organizational units, total costs are relatively similar for PC and UC 
patients. No ambiguous cost difference is identified on a significant trend. However, for total 
ward costs PC patients are significantly higher as compared to UC patients.  
Empirical Results  38 
The results within the organizational units show a clear trend that PC patients have lower costs 
than UC patients from the perspective of total costs and costs per day in radiology, ICU and 
surgery room. An opposite effect is shown for hotellery costs. Emergency room and ward have 
lower costs per day for PC patients than UC patient. Conversely, total costs in those two units 
are higher for PC patients compared to UC patients.  
The cost types catering, laboratory, material, other, pharmacy and room costs show a clear 
trend in terms of both total and costs per day. Of these, catering and room costs demonstrate 
that PC patients are more expensive than UC patients, while the others show the opposite. 
Patientmanagement and staff have lower costs per day, however, higher total costs for PC 
patients as compared to UC patients (except for staff costs per day considering all organiza-
tional units).  
For the staff groups nursing, social counselling and therapist, the unambiguous direction is 
found that PC patients have higher costs than UC patients. Table 13 presents the same results 
for physician cost per day considering ward only, whereas all other physician costs show the 
opposite trend.  
In light of the heterogeneous results overall as well as within all three clusters no clear state-
ment can be made, whether PC patients have indeed lower hospital costs as compared to UC 
patients. Therefore, hypothesis 1 cannot be accepted unequivocally, which leads to the follow-
ing conclusion:  
Hypothesis 1 
Hospital costs are lower for PC patients compared to 
UC patients who died in the hospital. 
Rejected 
6.2.3 Palliative Care Intervention 
6.2.3.1 Total Costs 
The following section concentrates on PC patients (n = 104) and, in particular, compares the 
costs before and after a patient receives a PC intervention. As described in chapter 5.3.2, the 
unadjusted means are presented for the pre- and post-intervention groups. These numbers 
are for illustrative purposes only and do not serve for interpretation. In order to compare “ap-
ples with apples”, the mean difference is shown as bias-corrected mean difference (outcome 
mean difference) with bias-corrected 95 % CI. Therefore, the outcome mean difference is the 
relevant statistical number and will be interpreted in the following. 
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Figure 20: Total costs before and after a PC intervention 
Figure 20 illustrates that in total, costs per patient for all organizational units before the PC 
intervention were CHF 3'441 per patient lower than after the PC intervention (p=0.131). This 
gap can be explained by the significant difference in the LOS (p=0.000). Patients stay on av-
erage 4.5 days longer in the hospital after a PC intervention as compared to the time before a 
PC intervention. The difference is even larger considering ward costs only (p=0.000). The re-
sults show that total ward costs are CHF 5’541 per patient higher after a PC intervention 
(p=0.001).  
 
Figure 21: Total costs per organizational unit before and after a PC intervention 
Even though overall total costs per patient are higher after a PC intervention, the organizational 
units emergency room (p=0.001), radiology (p=0.041), ICU (p=0.000) and surgery room 
(p=0.003) have significantly lower total costs after a PC intervention (see figure 21). This ob-
servation is reasonable since patients visit these units generally at the beginning of their hos-
pital stay. However, the higher costs in hotellery and ward after a PC intervention overcom-
pensate the aforementioned effects. While a PC intervention leads to significantly higher hotel 
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costs by CHF 917 (p=0.000), ward costs increase by CHF 5’542 on a significant level 
(p=0.001). 
 
Figure 22: Total costs per cost type before and after a PC intervention 
Analyzing the different cost types according to “Cluster 2”, significant differences can be with-
drawn from catering (p=0.000), patientmanagement (p=0.001), room (p=0.000) and staff costs 
(p=0.031), for which costs are higher after a PC intervention (see figure 22). The only cost 
types showing a significantly lower results after a PC intervention are laboratory (p=0.000) and 
pharmacy costs (p=0.011). Material costs are almost unchanged (CHF 24 less after a PC in-
tervention) (p=0.849). 
 
Figure 23: Total costs per staff group before and after a PC intervention 
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The greatest absolute difference is found within staff costs, of which nursing (p=0.000), social 
counselling (p=0.000) and therapist costs (p=0.006) significantly increase after a PC interven-
tion (see figure 23). The overall staff cost effect is reduced by the significantly lower physician 
costs after a PC intervention (p=0.025).  
 
Figure 24: Total ward costs per cost type before and after a PC intervention 
A filtered look only at the ward costs is necessary to understand the cost effects in a high-
volume setting (e.g. ICU and surgery room), which particular occur at the beginning of a pa-
tient’s stay and, thus, in most cases before the PC intervention. Although, total ward costs per 
patient before and after the intervention differ significantly by CHF 5’542 (p=0.001) (see fig-
ure 21), individual cost types show diverting results (see figure 24). Laboratory (p=0.000), other 
(p=0.000), pharmacy (p=0.034) and staff costs (p=0.000) are significantly different after a PC 
intervention. Out of these, laboratory along with pharmacy costs are the only cost types on the 
ward that are reduced after a PC intervention. Material, other and staff costs increase after a 
PC intervention, with total staff costs rising the most by the absolute amount of CHF 5’955.  
Figure 25 shows that all individual staff costs on the ward increase after a PC intervention with 
nursing (p=0.000), social counselling (p=0.000) and therapist costs (p=0.006) showing signifi-
cant results.  
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Figure 25: Total ward costs per staff group before and after a PC intervention 
6.2.3.2 Costs per Day 
The following section analyses the costs before and after a PC intervention under considera-
tion of the patients’ LOS before and after a PC intervention. In particular, the costs per day 
need to be interpreted considering the significantly longer LOS of 10.6 days after a PC inter-
vention as compared to a LOS of 6.1 days before a PC intervention. Hence, the results from 
the perspective of the average costs per day per patient are analyzed. First, the results of all 
organizational units are provided and, second, the findings concerning the costs occurred on 
the ward only.  
 
Figure 26: Costs per day before and after a PC intervention 
Breaking the total costs down on a daily basis (see figure 26), the average costs per day after 
a PC intervention are increased by CHF 211 above the daily costs per patient before a PC 
intervention (p=0.241). For ward only, costs per day are significantly CHF 468 higher per pa-
tient (p=0.001). 
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Figure 27: Costs per day before and after a PC intervention over the first 10 inhospitalised days 
Figure 27 demonstrates the distribution of the average costs per day of the patients’ 10 inhos-
pital days before and after the PC intervention. The graph illustrates that the costs rise consid-
erable at the time of the PC intervention (day 0). After a PC intervention the gap between both 
graphs decreases indicating the increasing dominance of ward costs.  
 
Figure 28: Costs per day per organizational unit before and after a PC intervention 
Similar to the results for total costs per patient, the organizational units emergency room 
(p=0.001), ICU (p=0.018) and surgery room (p= 0.004) have significantly lower costs per day 
after a PC intervention (see figure 28). By contrast, hotel (p=0.000) and ward costs per day 
(p=0.000) increase significantly after a PC intervention.  
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Figure 29: Costs per day per cost type before and after a PC intervention 
Figure 29 shows mixes results concerning the costs per cost type. Catering (p=0.000), patient-
management (p=0.000) and room costs per day (p=0.000) are significantly higher after a PC 
intervention. In contrast, laboratory (p=0.000), pharmacy (p=0.025), material (p=0.875), other 
(p=0.804) and staff costs (p=0.179) decrease after a PC intervention.  
 
Figure 30: Costs per day per staff group before and after a PC intervention 
Contrasting the overall trend for total staff costs in section 6.2.3.1, figure 29 revealed that the 
staff cost per day decrease by CHF 572 per patient per day. The biggest difference to total 
costs per staff group lies in nursing, for which the average costs per day get increase only 
marginally by CHF 86 after a PC intervention (see figure 30). Thus, the finding is not significant 
(p=0.531). Social counselling (p=0.000) and therapist costs per day (p=0.001) increase after a 
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PC intervention. Physician costs per day (p=0.022) significantly decrease after a PC interven-
tion.  
Figure 31: Ward costs per day per cost type before and after a PC intervention 
Focusing on the costs per day for each patient that occurred on the ward only, different results 
as compared to the findings considering all organizational units are found (see figure 31). De-
viations can be shown for material (p=0.000), other (p=0.025) and staff costs per day 
(p=0.000), which are higher after a PC intervention considering ward costs only. Laboratory 
(p=0.001) and pharmacy costs per day (p=0.188) still have the same trend, i.e. costs per day 
decrease after a PC intervention.  
 
Figure 32: Ward costs per day per staff group before and after a PC intervention 
Analyzing the individual staff groups, the average costs per day that occurred on the ward only 
(see figure 32), increase after a PC intervention for nursing (p=0.000), physician (p=0.009), 
social counselling (p=0.000) and therapist costs (p=0.001).  
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6.2.3.3 Interim Conclusion 
On the whole, the different sub-studies examine for all three clusters (i) the total costs per 
patient as well as (ii) the average costs per day per patient before and after a PC intervention. 
Table 14 summarizes the cost development after a PC intervention. While a black shaded field 
with an upwards-facing arrow indicates that costs after a PC intervention increase, a non-
shaded (white) field with a downwards-facing arrow suggests the opposite. The asterisk indi-
cates that the result is significant on the 5 % level. Grey shaded fields present ambiguous 
results or costs that are not examined in any of the sub-studies.  
 
Table 14: Cost difference before vs. after a PC intervention 
Overall, total costs per patient for all organizational units as well as for ward only increase after 
a PC intervention. The same trend is found for average costs per day per patient. 
All organizational units show the same cost trend comparing total cost and average costs per 
day per patient. This allows a clear statement that emergency room, radiology, ICU and sur-
gery room costs decrease after a PC intervention. On the contrary, after a PC intervention, 
hotel and ward costs increase.  
With respect to the cluster 2 “cost types”, catering, patientmanagement and room costs show 
for all four analyses the same trend resulting in higher costs after a PC intervention. In contrast, 
laboratory and pharmacy costs experience lower costs after a PC intervention. Material costs 
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are lower after a PC intervention regarding all organizational units, but tend to be higher if only 
ward costs are examined. Staff and other costs are higher after a PC intervention when ob-
serving total costs per patient and costs per day per patient for ward only, but tend to be lower 
when analyzing costs per day per patient for all organizational units.  
Examining the individual staff groups (cluster 3) unambiguous statements can be made from 
both perspectives (total costs and costs per day per patient) for nursing, social counselling and 
therapist costs that costs increase after the PC intervention. The same trend is shown for phy-
sician costs considering solely ward costs. Physician costs decrease after the PC intervention 
in the “all organizational units” analysis.  
In summary, the assumed decrease of ancillary costs (see chapter 4) does not outweigh the 
increase in personnel expenses after a PC intervention, as hypothesized. Therefore, the above 
results lead to the following conclusion regarding hypothesis 2:  
Hypothesis 2 
A PC intervention reduces hospital costs for patients 
who died in the hospital.  
Rejected 
6.2.4 Timing of PC Interventions  
6.2.4.1 Total Costs 
This section is concerned with the timing of the PC intervention to further understand potential 
patterns of savings. For that purpose, all 104 PC patients are clustered according to the timing 
of their PC interventions. In line with the classification in the literature (Fitzpatrick et al., 2018), 
all patients who receive a PC intervention during the first three days after hospital admission 
are considered to be “early PC patients”. On the other hand, patients who receive a PC inter-
vention later than three days after hospital admission are grouped as “late PC patients”. Both 
groups have about the same number of patients with early PC patients consisting of 54 and 
late PC patients of 50 patients. A detailed table comparing the patient characteristics of these 
two groups is provided in Appendix II.  
Figure 33: Total costs comparing early to late PC patients  
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Figure 33 illustrates that total costs per patient are significantly higher for late PC patients than 
for early PC patients (p=0.000). The difference gets smaller for total costs considering ward 
costs only. Just like the analysis before (pre- vs. post-intervention), the relevant and interpret-
able numbers are the outcome mean differences, which are bias-corrected. The mean num-
bers for early and late PC patients are for illustrative purposes only and do not serve for inter-
pretation.  
Figure 34: Total costs per organizational unit comparing early to late PC patients 
Figure 34 describes the total cost differences between early and late PC patients for different 
organizational units. Late PC patients have higher costs in all organizational units as compared 
to early PC patients except for emergency room costs (p=0.330). However, statistically signif-
icant differences are solely found for total hotel (p=0.000) and ward costs (p=0.000).  
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Figure 35: Total costs per cost type comparing early to late PC patients 
A clear trend is found for all cost types in figure 35, for which late PC patients have higher 
costs than early PC patients. Significant results can be found for total catering (p=0.001), la-
boratory (p=0.000), material (p=0.038), pharmacy (p=0.002), room (p=0.000) and staff costs 
(p=0.000). Hereby, the greatest absolute differences show pharmacy and staff costs. 
 
Figure 36: Total costs per staff group comparing early to late PC patients 
The observation that late PC patients are more expensive than early PC patients is also sup-
ported for all individual staff groups (see figure 36). Total costs for nursing (p=0.000), physician 
(p=0.000), social counselling (p=0.007) and therapist (p=0.013) are significantly higher for late 
PC patients than for early PC patients. 
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Figure 37: Total ward costs per cost type comparing early to late PC patients 
Similar results can be withdrawn for all cost types considering total costs that occurred on the 
ward only (see figure 37). Again, the late PC patients’ costs for laboratory (p=0.000), material 
(p=0.002), other (p=0.608), pharmacy (p=0.002) and staff (p=0.000) are above the correspond-
ing costs for early PC patients.  
 
Figure 38: Total ward costs per staff group comparing early to late PC patients 
Figure 38 illustrates that total ward costs for all individual staff groups are significantly higher 
for late PC patients than for early PC patients. 
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6.2.4.2 Costs per Day 
The following section presents the results from the perspective “average costs per day per 
patient”.  
 
Figure 39: Costs per day comparing patients with early vs. late PC intervention 
Overall, early PC patients account for slightly less costs per day than late PC patients 
(p=0.369) (see figure 39). This can be explained by the significant difference in LOS (p=0.000), 
as late PC patients stay on average 11.3 days longer in the hospital than early PC patients. 
Considering ward only, costs per day are significantly CHF 221 (p=0.036) higher for late PC 
patients. 
 
Figure 40: Costs per day for early and late PC patients on each of the first 20 inhospitalised days 
Figure 40 presents the distributions of the costs per day for the early and late PC patient group 
for each of the first 20 days of hospital stay. The distributions illustrate that late PC patients 
have higher costs on almost each day of the 20-day period. The longer the patient stays in the 
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hospital, the smaller the difference gets between the daily costs. Even the opposite effect is 
found for some days at the end of the period. 
 
Figure 41: Costs per day per organizational unit comparing early to late PC patients 
The analysis of the costs per day for the different organizational units provides mixed results 
(see figure 41). Emergency room (p=0.065), hotel (p=0.000), radiology (p=0.639) and ICU 
(p=0.676) experience lower costs per day for late PC patients than for early PC patients. Sur-
gery room and ward costs per day, on the other hand, have higher costs per day for late PC 
patients than for early PC patients.  
 
Figure 42: Costs per day per cost type comparing early to late PC patients 
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In addition, figure 42 reveals different observations comparing early PC patients to late PC 
patients for the defined cost types. While catering (p=0.948), laboratory (p=0.122), material 
(p=0.177), pharmacy (p=0.046) and staff costs per day (p=0.035) are higher for late PC pa-
tients than for early PC patients, other (p=0.058), patientmanagement (p=0.000) and room 
costs per day (p=0.001) show the opposite direction. 
 
Figure 43: Costs per day per staff group comparing early to late PC patients 
As shown in figure 43, except for physician costs per day (p=0.406), all individual staff groups 
have higher costs per day for late PC patients as compared to early PC patients. Of these, 
solely social counselling costs per day (p=0.027) show a significant difference. 
 
Figure 44: Ward costs per day per cost type comparing early to late PC patients 
Focusing not on organizational units but on ward only, similar trends are found for the different 
cost types (see figure 44). Except for other costs per day (p=0.003), all cost types have higher 
costs for late PC patients as compared to early PC patients. All of the cost types show signifi-
cant results, except for staff costs per day (p=0.654). 
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Figure 45: Ward costs per day per staff group comparing early to late PC patients 
Similar to the analysis for all organizational units, nursing (p=0.181), social counselling 
(p=0.057) and therapist costs per day for ward only (p=0.153) are higher for late PC patients 
than for early PC patients (see figure 45). Solely physician costs per day show the opposite 
direction, however, not on a significant level (p=0.193). 
6.2.4.3 Interim Conclusion 
Table 15 summarizes the above presented results and, on this basis, provides an interim con-
clusion. A black shaded field with an upwards-facing arrow indicates that late PC patients have 
higher costs than early PC patients. A non-shaded (white) field with a downwards-facing arrow 
presents the opposite direction. The asterisk is added to an arrow if the result is significant on 
the 5 % level. Grey shaded fields are used for ambiguous results or costs that are not examined 
in any of the sub-studies.  
In total, the results provide evidence that costs for late PC patients are higher than for early 
PC patients from both perspectives (total costs and costs per day).  
However, the results within each of the sub-studies differ for some analyzed costs. For the 
organizational units hotel, radiology and ICU, for instance, although total costs are higher for 
late PC patients than for early PC patients, the opposite effect is shown for costs per day. 
Solely surgery room and ward costs have the same as the overall trend for both total costs 
and costs per day. The emergency room costs are lower for late PC patients than for early PC 
patients. 
Most of the cost types present unambiguous results from all four cost perspectives, i.e. cost 
for late PC patients are higher than for early PC patients. These cost types include catering, 
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laboratory, material, pharmacy and staff costs. The same trend is found for total other, patient-
management and room costs based on total costs per patient. However, the opposite trend 
can be shown for costs per day. 
Individual staff groups also reveal a clear trend. Nursing, social counselling and therapist costs 
are higher for late PC patients than for early PC patients. Physician is the only staff group that 
has lower costs for late PC patients as compared to early PC patients from the perspective of 
costs per day.  
 
Table 15: Cost difference comparing late to early patients 
The overall results lead to the conclusion that early PC patients have lower costs as compared 
to late PC patients. Therefore, the following conclusion is drawn regarding hypothesis 3:  
Hypothesis 3 
Patients with an early PC intervention have lower 
hospital costs compared to patients with a late PC 
intervention who died in the hospital. 
Verified 
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7 Conclusion 
7.1 Main Findings and Discussion 
This thesis examines the overall research question (developed in section 1.3), whether PC 
reduces hospital costs for adult patients with a non-accidental death. It investigates the cost 
avoidance potential of PC interventions from different perspectives. First, the study compares 
the costs of UC to PC patients. Second, it analyses the costs of a patient’s pre- and post-
intervention hospital stay and third, it focuses on the timing of PC interventions. The results 
contribute to the literature comprehensive information on hospital costs by shedding light on 
different organizational units as well as individual cost types of a hospital. The study enhances 
transparency for internal and external stakeholders and can serve as a potential controlling 
instrument. Table 16 summarizes the study’s results with respect to its hypotheses. 
 
Table 16: Hypothesis test results 
Following the existing literature, the findings concerning the first hypothesis reveal that PC 
patients have lower costs per day considering both all organizational units as well as ward 
only. However, different from the existing literature, total costs (considering all organizational 
units) are on a similar level for PC and UC patients. Total ward costs are even higher for PC 
patients as compared to UC patients. This effect can be attributed to the significantly longer 
ALOS of PC patients. Hypothesis 1 is rejected as the different sub-studies provide mixed re-
sults. 
The second study focuses on the PC group and analyses the costs before and after the PC 
intervention. Hypothesis 2 suggests that average hospital costs decrease after a PC interven-
tion. However, the results show the opposite effect based on total costs for both scenarios (all 
organizational units as well as ward only). This observation is also supported by costs per day. 
The expected decrease of ancillary costs such as laboratory and pharmacy does not over-
weight the increase in overall staff costs. Therefore, hypothesis 2 is rejected. 
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An important cost-determining factor is the timing of the PC intervention, which is analyzed in 
the third examination. Following the existing literature, the findings provide evidence that pa-
tients with an early PC intervention within the first three days after hospital admission com-
pared to patients receiving a later PC intervention (after more than three days after hospital 
admission) have lower total costs as well as lower costs per day per patient considering both 
scenarios (all organizational units and ward only). Thus, hypothesis 3 is verified. 
In the following, the results of the three analyses are summarized according to the organiza-
tional units (cluster 1), cost types (cluster 2) and individual staff groups (cluster 3). In this sec-
tion’s tables, a down warded arrow with a non-shaded field indicates for the column “Hypoth-
esis 1” that PC patients have lower costs as compared to UC patients. The same arrow demon-
strates for the column “Hypothesis 2” that costs decrease after a PC intervention. For the col-
umn “Hypothesis 3”, the down warded arrow shows that the costs for patients who receive a 
late PC intervention are lower compared to patients with an early PC intervention. An up 
warded arrow with a black shaded field indicates the opposite as the down ward-looking arrow 
in all three columns. The double-directional arrow expresses mixed results.  
 
Table 17: Test results for cluster 1 “Organizational units”  
Table 17 describes the test results for cluster 1. Within the organizational unit emergency 
room, PC patients have lower costs per day compared to UC patients. However, total costs 
are higher for PC as compared to UC patients (hypothesis 1). Costs are lower in the emergency 
room after a patient receives a PC intervention (hypothesis 2). In addition, a late PC interven-
tion reduces costs in the emergency room (hypothesis 3). In general, emergency room costs 
occur mostly in the beginning of a patient’s hospital stay. Therefore, they are not evenly dis-
tributed.  
Costs for hotel services are higher for PC patients as compared to UC patients. These costs 
also rise after a patient receives a PC intervention. For PC patients, a higher proportion of 
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single rooms, catering according to their special needs as well as an increased patient admin-
istration on leaving the hospital might be reasons for these effects. Mixed results are found for 
the timing of the PC intervention. A late PC intervention is associated with lower hotel costs 
per day compared to an early PC intervention. However, total hotel costs are higher for late 
PC patients due to the significant longer ALOS as compared to early PC patients. 
Radiology, ICU and surgery room costs have the same trend for hypothesis 1 and 2. For 
these units, costs for PC patients are below the costs for UC patients. Moreover, costs are 
lower after a patient receives a PC intervention. A decrease offer in therapies for PC patients 
compared to UC patients or after a PC intervention might be the reason for these effects. The 
focus of PC patients lies in the relief of suffering and the treatment of pain and other problems 
(WHO, 2018). With respect to hypothesis 3, radiology and ICU have similar ambiguous results 
as hotel costs suggesting that an early PC intervention is associated with higher costs per day 
and lower total costs as compared to patients who receive a late PC intervention. This can be 
explained by the significantly longer ALOS for late compared to early PC patients. The effect 
that late PC patients undergo surgery significantly more often than early PC patients might 
explain the finding that surgery room costs are higher for patients who receive a late PC inter-
vention from both cost perspectives. 
While ward costs per day are lower for PC patients as compared to UC patients, total ward 
costs show the opposite effect. The result is explainable due to the longer ALOS of PC patients 
compared to UC patients. Within the ward, costs from both perspectives rise after a patient 
receives a PC intervention. In this organizational unit, in particular catering, room and staff 
costs are the main cost drivers. Furthermore, an unambiguous result can be withdrawn from 
the timing of a PC intervention. Ward costs are lower for patients who receive an early PC 
intervention as compared to patients with a late PC intervention. This outcome suggests a 
great potential for cost savings when timing PC patients. 
From the perspective of cluster 1 “organizational units”, the results show that the increase in 
total costs in the units emergency room, hotel and ward for PC patients as compared to UC 
patients is limited by the lower total costs in radiology, ICU and surgery. Even though emer-
gency room, radiology, ICU and surgery room costs are lower after a PC intervention, the 
increased hotel and ward costs overcompensate this effect. The findings reveal that PC pa-
tients cause in general less costs in organizational units with a high level of technical equip-
ment and staff resources. Hypothesis 3 is verified based on the results of the total cost analy-
sis. Except for emergency room, all other organizational units have higher total costs for late 
PC patients as compared to patients who receive a PC intervention within three days after 
hospital admission. One reason for this effect is that early PC patients visit expensive hospital 
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units such as ICU and surgery rooms less often than late PC patients. A quick and direct 
transfer to the PC ward is aimed.  
 
Table 18: Test results for cluster 2 “Cost types”  
The summarized results for the cluster 2 studies (“cost types”) are presented in table 18. The 
results of the first analysis show that catering and room costs are higher for PC patients as 
compared to UC patients. In addition, catering and room costs increase after a PC intervention. 
In general, PC patients receive food from the hospital that is specially adapted to their individ-
ual needs. They also have the possibility of staying in single instead of shared rooms. The 
higher prices for food supply and rent might explain these findings, which are also supported 
by May et al. (2015). Patients that receive a late PC intervention have higher total catering and 
room costs than patients with an early PC intervention. Even the significant difference of ALOS 
between both groups does not turn the effect for daily catering costs. This indicates that the 
timing controlling of patient flows can have a positive cost saving effect on the food supply. 
Room costs per day are lower for early than for late PC patients due to their shorter ALOS.  
PC patients have lower average laboratory and pharmacy costs than UC patients. Within the 
PC group, laboratory and pharmacy costs decrease after a PC intervention. The results of this 
thesis are in line with most of the studies that also examine these two cost types (e.g. Morrison 
et al. (2011), Penrod et al. (2008)). Laboratory testing and the giving of expensive medication 
such as cancer products is reduced to a minimum since the focus for PC patient lies in pain 
treatment (WHO, 2018). This might also explain the results of the third analysis in which a late 
PC intervention is associated with higher laboratory and pharmacy costs as compared to a PC 
intervention within the first three days after hospital admission from both cost perspectives.  
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A clear trend is found for material and other costs comparing UC to PC patients. These costs 
are lower for PC patients than for UC patients. While the cost type “other costs” can be ne-
glected for further discussions, the findings for material might indicate that similar to laboratory 
testing and the use of pharmacy products, also the use of material is limited for PC patients 
since the treatment focus has changed. So far, solely Cowan et al. (2004) observed this cost 
type. Their findings are in line with this thesis. However, further research is necessary to un-
derstand the full impact of material costs. Contradictory results are shown within the PC group. 
While material costs are lower after a PC intervention considering all organizational units, for 
ward only, material costs are higher after a PC intervention. This demonstrates that material 
costs mainly occur in organizational units such as ICU and surgery room. Furthermore, it might 
also indicate that PC patients on the ward receive high-priced materials. The results of the 
third analysis show that material for all cost perspectives are unambiguously higher for patients 
who receive a late PC intervention as compared to patients with an early PC intervention. One 
explanation for this result could be that late PC patients enter units that require more material 
such as emergency rooms and ICU significantly more often than early PC patients. This leads 
to the conclusion that the use of high-priced materials is more frequent for late PC patients 
compared to early PC patients. Further research could analyse in more detail the meaningful 
use not only of materials but also of pharmacy products and laboratory testing. 
Average daily patientmanagement costs are lower for PC patients as compared to UC pa-
tients (hypothesis 1) as well as lower for patients receiving a late PC intervention than for 
patients with an early PC intervention (hypothesis 3). However, the opposite trend is found for 
both of the aforementioned analyses regarding total patientmanagement costs. This effect can 
be explained by the longer ALOS of PC patients compared to UC patients since total patient-
management costs are evenly distributed amongst a patient’s hospital stay. The study provides 
unambiguous evidence concerning the patientmanagement costs before and after a PC inter-
vention as these costs are significantly higher after the PC intervention. This indicates a higher 
administrative effort for PC patients compared to UC patients. The coordination of multiple staff 
groups, frequent changes of organizational units or the greater involvement of family and 
friends might be reasons for this finding.  
Total staff costs for PC patients are above the corresponding staff costs for UC patients and, 
are on average higher after a patient receives a PC intervention. This fact can be traced back 
to the significantly longer ALOS for PC patients compared to UC patients. The same trend is 
found for average daily staff costs considering ward costs only. Organizational units such as 
emergency room, surgery and ICU are more personnel intense compared to a ward. This might 
explain that staff costs per day within all organizational units are lower for PC patients than for 
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UC patients and decrease after a PC intervention. The results show a clear trend comparing 
early and late PC patients. Late PC patients have higher staff costs than patients who receive 
a PC intervention within three days after their hospital admission. One reason for that finding 
is that late PC patients admit personnel intense organizational units such as ICU and surgery 
room significantly less than early PC patients. Following May et al. (2015), prioritizing critically 
ill patients could therefore maximize savings. Since staff costs account for about 64.5 % of 
Swiss hospital revenues (PwC, 2018), it is surprising that none of the aforementioned studies 
have focused on this very important cost type. More research is therefore necessary to under-
stand the full impact of staff deployment. 
On the whole, comparing the hospital costs of UC and PC patients with respect to hypothesis 1, 
the results of the cost type based analysis reveal that the increased total catering, room, pa-
tientmanagement and staff costs for PC patients as compared to UC patients are compensated 
by the decreased total laboratory, material, other and pharmacy costs. Within the PC patient 
group, after a PC intervention, the higher catering, patientmanagement and room costs over-
compensate the decreasing cost trend for laboratory and pharmacy as well as the mixed ef-
fects for material, other and staff costs (hypothesis 2). The findings for the timing of a PC 
intervention (hypothesis 3) reveal that catering, laboratory, material, pharmacy and staff costs 
are higher for patients who receive a late PC intervention as compared to patients receiving 
an early PC intervention. This effect overcompensates the mixed results for other, patientman-
agement and room costs.  
 
Table 19: Test results for cluster 3 “Staff detail”  
Cluster 3 describes the staff costs in more detail by disaggregating the staff cost type further 
(see table 19). Unambiguous results are found for the staff groups nursing, social counsel-
ling and therapists, for which PC patients have lower costs compared to UC patients. In ad-
dition, nursing, social counselling and therapist costs increase after a PC intervention. For the 
same staff groups, patients receiving a late PC intervention have higher total costs compared 
to patients with an early PC intervention. The increased caring and consulting services that 
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patients receive from the hospital staff as soon as they are considered as PC patients might 
explain these clear results. 
The same trend is observed in all three analyses for average daily physician costs considering 
ward only. For all other cost perspectives, physician costs are higher for PC patients than for 
UC patients. This finding might additionally illustrate the shift from treating the illness to more 
caring services for the patient. Within the PC group, contradictory results are examined for 
physician costs. While physician costs are less after a PC intervention considering all organi-
zational units, for ward only, physician costs increase after a PC intervention. That finding 
could be related first to the fact that organizational units such as surgery, ICU or emergency 
room have an extremely high physician input and second that patients enter these units mainly 
in the beginning of their hospital stay. The results for the third analysis show that total physician 
costs are higher for patients who receive a late PC intervention as compared to patients with 
an early PC intervention. However, average daily physician costs for patients with a late PC 
intervention are below the corresponding costs for patients with an early PC intervention. One 
reason is the significant difference in ALOS for both PC groups. However, this finding is unex-
pected since one might assume that daily physician costs for early PC patients should be less 
than for late PC patients since late PC patients admit high-personnel units such as surgery 
room and ICU more often than early PC patients. Additional research is necessary proving this 
result. 
7.2 Implications 
Specific interventions such as in PC have different economic implications for multiple stake-
holders in the healthcare sector who guide and allocate limited resources. Even though this 
thesis does not evaluate the quality of PC programs, its results can provide arguments and 
incentives for health insurance companies, policy makers, hospital management, medical staff 
and the society to promote and expand PC programs from an economic point of view.  
Costs per day are lower for PC patients than for UC patients. However, PC patients stay on 
average 8.8 days longer in the hospital than UC patients. This results in approximately the 
same costs for PC and UC patients. Disregarding other results, health insurance companies 
would hence, not be advised to promote PC. Reducing the ALOS of PC patient in hospitals 
would be one option to save costs. However, the problem in Switzerland is that there are only 
very few institutions with an adequate follow-up treatment. Therefore, health insurance com-
panies are advised to direct resources towards evaluative and research projects. Further anal-
yses could broaden the understanding of dealing with terminally ill patients and lead to better 
Conclusion  63 
prediction algorithms and improved allocation of resources (Fassbender et al., 2009). Promot-
ing early PC, supporting PC institutions and finding adequate financial compensation solutions 
might be additional measures to maintain the quality of care and remain financially stable.  
Independent of this thesis’ results, politics must first clarify the question: “what do we want to 
afford for our society?” If politicians decide to widely use PC, which is indisputable in the broad 
literature, they should commit themselves, also from an economic point of view, to a clear 
strategy whether to promote PC or not. The strategy should focus on the inpatient (stationary) 
and the outpatient (ambulatory) health care sector and provide financial incentives for all insti-
tutions dealing with terminally ill patients. National strategies aimed at increasing access to 
and availability of PC should be implemented by the politics in order to promote early PC. Since 
PC is not yet widely spread in Switzerland and beyond, an expansion of PC could also lift 
synergies and might lead to the effect of positive economies of scale, considering the level of 
output as the level of input increases (Eastaugh, 1992). 
This thesis further serves as a cost calculation model, which could be adapted for other hos-
pitals to get a detailed analysis of the cost financials. Hospital management might be encour-
aged to analyze specific cost types that might be the main triggers influencing the costs in PC. 
This might serve as a controlling instrument for potential cost saving strategies without de-
creasing the quality of care. In addition, synergies within the PC department and with other 
medical departments can be lifted. Hospital management is also recommended to frequently 
conduct compensation negotiations with health insurance companies. Since the results sug-
gest that costs can be reduced or avoided by an early involvement of PC, hospital manage-
ment should offer incentives for the medical staff to identify PC patients early after admission 
(Starks et al., 2013). Screening guidelines, defined processes or training courses could be 
helpful tools, the management can implement throughout the hospital. Creating and supporting 
an infrastructure for the medical staff performing routine assessments of terminal ill patients is 
essential (Downar, 2018). In addition, internal and external advertising activities might be able 
to enhance the awareness of PC with all stakeholders.  
The medical staff takes a major role when developing PC, as they are the basis for the im-
plementation of PC. Therefore, particularly physicians and nurses are encouraged to promote 
PC with their patients. Efforts must be made to improve the skills and comfort of physicians 
from all medical disciplines in introducing PC services. This education should be a mandatory 
part in all medical schools and be continued throughout the medical training and even after 
completion. However, this requires the willingness of participating in training approaches as 
well as accepting medical limits. Furthermore, the inclusion of primary care physicians is es-
sential for a holistic treatment approach (Enguidanos et al., 2009). 
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The results of the thesis are also important with respect to nurse education. Nurses are advised 
to pursue education in PC to understand the importance of an early integration of PC in the 
patient’s care plan. This would allow them to spend more quality time communicating with the 
patient and the patient’s family and friends. Besides this qualitative aspect, an early PC inter-
vention would also reduce costs. Since nurses are the medical staff group working closest with 
the patients, they can encourage the acceptance and trust of PC. Nurses can also directly 
introduce other PC team members directly to patients and its family and friends (Temel et al., 
2011). 
Other PC team members include social counselors and therapists who are encouraged to par-
ticipate in special training courses to understand the importance of the timely recognition of 
the need for PC in terminal ill patients. Due to an early PC intervention, costs can be lowered. 
It is essential for them to extend their competency responding to rapidly changing situations. 
Social counselors and therapists are advised to give special education to patient and its family 
and friends, which enables them to adjust and adapt to consequences of the illness (Physio-
pedia contributors, 2018). 
The above-mentioned implications for health insurance companies, politicians, management 
and hospital staff directly affect the overall society, whose awareness of the existence of PC 
programs would need to be increased as well if PC shall be generally pursuit as a high-quality 
treatment. Therefore, it is important to improve knowledge of and access to PC services by, 
for instance, publicity campaigns, open talks, or clear signposting from healthcare profession-
als. The public is encouraged to break a taboo in society and loose the reluctance of talking 
about death and dying not only with health care professionals, but also with family and friends 
(McIlfatrick et al., 2013). 
Overall, for all health care professionals, Simoens et al. (2010) suggest that the “switch from 
a curative approach to palliative care support needs specific attention […].”  
7.3 Limitations and Outlook 
When reading and transferring the results of this empirical thesis, the following limitations need 
to be considered. In particular, the generalizability of the study’s results might be difficult. The 
empirical investigation uses data from one University hospital and focuses solely on the hos-
pital sector (May et al., 2014). Hence, additional data would be necessary to test the total 
financial impact of PC programs on health systems. Moreover, a larger patient sample would 
give the opportunity to make comparisons in between different illness groups, e.g. comparing 
cancer and neurological patients.  
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A comprehensive multicenter analysis that includes cost and medical data from other health 
care sectors such as elderly homes, rehabilitating institutions or home care might be important 
for stakeholders to identify cost patterns, draw conclusive statements and provide implications. 
(Khandelwal et al., 2016b). However, currently, it is difficult, yet impossible, to get access to 
the cost and medical data of other health care sectors.  
For pragmatic reasons, the thesis’ data was collected retrospectively. The analysis of prospec-
tive data was not feasible as no sufficient number of terminally ill patients whose treatment 
could be distinguished between UC and PC patients was found. In addition, this thesis exclu-
sively concentrates on patients that died in the hospital in the year 2015. However, less than 
40 % of the patients who spent time on the hospitals’ PC ward also die in the hospital. On the 
other hand, more than 60 % of the patients who spent time on the PC ward are discharged 
from the hospital alive. To avoid different severities between those discharge groups, future 
research should enlarge the sample and include all patients’ discharches (alive and dead).  
Further potential options to enhance the sample size include the inclusion of other hospitals 
with PC departments. Examining different hospital types, such as private, non-profit and public 
hospitals, might lead to additional meaningful results. This thesis focuses on Switzerland only. 
An international comparison between, for instance, German-speaking countries like Germany 
and Austria, would not only increase the sample size, but also provide a better basis for reim-
bursement negotiations between hospitals, politics and health insurance companies. In addi-
tion, further research should increase the time range and extend the thesis’ one-year time 
horizon. A longitudinal study would allow a better understanding of the impact of the costs from 
different organizational units and cost types (Khandelwal et al., 2016a). 
Another limitation might be the potential self-selection bias, which “arises when a rule other 
than simple random sampling is used to sample the underlying population” (Heckman, 2010). 
Consequently, the true population is not accurately described. This thesis tries to reduce this 
problem by simple and clear exclusion criteria, and thus, reducing the initial sample by almost 
one-fourth (230 patients).  
This study defines a PC patient as a patient who receives PC on the ward or a PC consultation. 
However, it does not distinguish between both interventions. Further research could examine 
the cost difference between those two PC groups. The thesis’ findings that an early PC inter-
vention is associated with reduced hospital costs also supports the need for further research. 
The comparison of early and late PC patients to the corresponding UC patients is essential to 
understand the total impact on overall hospital costs.  
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This study concentrates on the quantitative cost analyses only. Further research could add 
qualitative aspects such as the satisfaction of patients and their family members.  
With respect to the study’s statistical methodology, propensity-score matching might fail to 
adjust adequately for unmeasured variables. Psychosocial factors and unobserved complica-
tions in a patient’s condition throughout the hospital stay may affect the cost estimates. How-
ever, this thesis attempts to provide a valid comparison between PC and UC patients as well 
as within the PC group by adjusting for all of the observational data of patients at the time of 
hospital admission (McCarthy et al., 2015).  
This study is the first one, which provides a comprehensive and detailed overview of different 
organizational units and cost types that are related to PC and UC patients who died in a hos-
pital. There is a great need for additional quantitative retrospective and prospective research 
on inhospitalised PC for both national and international settings. Further investigation is crucial 
to reimbursement policies encouraging PC (Kozlov et al., 2015). Since this study concentrates 
on quantitative data only, further research could add qualitative aspects such as the satisfac-
tion of patients and their family members.  
Considering the total cost findings, health care professionals might hope that the qualitative 
aspects supporting PC outweigh the financial cost observations. However, PC costs must be 
evaluated from the general concern about the overall costs of health services including the 
expenses at the end of life. This means that like any other health services, PC will always have 
to compete with the alternative use of the same money. Because health care resources are 
more limited than health care desires, the financial self-sufficiency of health services, including 
PC interventions, is of crucial importance for the Swiss health system (Smith et al., 2009). 
Overall, this thesis provides empirical evidence, which might be able to support stakeholders 
from the healthcare sector to promote and enlarge PC services for their individual reasons. 
Khandelwal et al. (2016b) argue that, “value in healthcare is key to controlling costs and im-
proving quality.” The financial justification of hospital costs should never be the primary ra-
tionate promoting PC. However, it can be a useful secondary benefit to offer a cost avoidance 
strategy along with the improvement of the quality of care. PC is considered a priceless benefit 
and, in contrast to birth, the full measure is not appreciated by many people until the moment 
of need (McCarthy et al., 2015). Decision-makers should keep in mind that death is exactly as 
birth, an inevitable part of every life and, therefore, concerns all of us. 
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